Roles of miRNAs in regulating ovarian cancer stemness

Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of o...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. Reviews on cancer Vol. 1879; no. 6; p. 189191
Main Author Chong, Zhi-Xiong
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.11.2024
Subjects
Animals
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
CSC
Female
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs - genetics
miRNAs
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Ovarian cancer
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Prognostic biomarkers
Signal Transduction
Therapeutic agents
NRP2
ZEB1/2
CDC
MDSC
JNK
WWC1
PTEN
CDK
TAZ
AREG
ERBB
SLUG
Ovarian cancer
MYLK
FOXQ1
MAML
OCT4
TMEM100
DNMT
UTR
PI3K
ALDH1
CtBP2
LATS
mTOR
GPR137
AML
NOD
CML
FGF
MST1
PTPN
BCL
ARID1A
ADAR2
DKK1
EMT
DDB2
IκBα
ADAM19
MEK
NA
SCNN1D
TBL1XR1
PIP3
PTPLAD2
DOCK1
PIP2
ABCG2
ERK
GAS7
HDAC
Prognostic biomarkers
lncRNA
miRNAs
LRP5
RTK
SAV
XIAP
YAP
LKB1
SCID
EGFR
SOCS3
CSC
miRNA
CSL
WAF1
SNAIL
CD
EGR1
NF-kß
HIF
CMTM4
GSK-3ß
VEGF
MYPT1
STAT3
IKK
HMGA2
RAB27A
AKT
KLF4
S100B
Therapeutic agents
DLG2
PAR2
MOB1
SP1
SFRP
NICD
BAX
NANOG
HOXD9
SOX
Online AccessGet full text

Cover

Abstract Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of ovarian CSC is a critical factor that promotes treatment resistance and frequent relapse among ovarian cancer patients, leading to poor clinical outcomes. MicroRNA (miRNA) is a short, non-protein-coding RNA that regulates ovarian CSC development. Although multiple original research articles have discussed the CSC-regulatory roles of different miRNAs in ovarian cancer, there is a deficiency of a review article that can summarize the findings from different research papers. To narrow the gap in the literature, this review aimed to provide an up-to-date summary of the CSC-regulatory roles of various miRNAs in modulating ovarian cancer cell stemness. This review will begin by giving an overview of ovarian CSC and the pathways responsible for driving its appearance. Next, the CSC-regulatory roles of miRNAs in controlling ovarian CSC development will be discussed. Overall, more than 60 miRNAs have been reported to play CSC-regulatory roles in the development and progression of ovarian cancer. By targeting various downstream targets, these miRNAs can control the signaling activities of PI3K/AKT, EGFR/ERK, WNT/ß-catenin, NF-kß, Notch, Hippo/YAP, EMT, and DNA repair pathways. Hence, these CSC-modulatory miRNAs have the potential to be used as prognostic biomarkers in predicting the clinical outcomes of ovarian cancer patients. Targeting CSC-promoting miRNAs or increasing the expressions of CSC-repressing miRNAs can help slow ovarian cancer progression. However, more in-depth functional and clinical trials must be carried out to evaluate the suitability, safety, sensitivity, and specificity of these CSC-regulating miRNAs as prognostic biomarkers or therapeutic targets. [Display omitted]
AbstractList Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of ovarian CSC is a critical factor that promotes treatment resistance and frequent relapse among ovarian cancer patients, leading to poor clinical outcomes. MicroRNA (miRNA) is a short, non-protein-coding RNA that regulates ovarian CSC development. Although multiple original research articles have discussed the CSC-regulatory roles of different miRNAs in ovarian cancer, there is a deficiency of a review article that can summarize the findings from different research papers. To narrow the gap in the literature, this review aimed to provide an up-to-date summary of the CSC-regulatory roles of various miRNAs in modulating ovarian cancer cell stemness. This review will begin by giving an overview of ovarian CSC and the pathways responsible for driving its appearance. Next, the CSC-regulatory roles of miRNAs in controlling ovarian CSC development will be discussed. Overall, more than 60 miRNAs have been reported to play CSC-regulatory roles in the development and progression of ovarian cancer. By targeting various downstream targets, these miRNAs can control the signaling activities of PI3K/AKT, EGFR/ERK, WNT/ß-catenin, NF-kß, Notch, Hippo/YAP, EMT, and DNA repair pathways. Hence, these CSC-modulatory miRNAs have the potential to be used as prognostic biomarkers in predicting the clinical outcomes of ovarian cancer patients. Targeting CSC-promoting miRNAs or increasing the expressions of CSC-repressing miRNAs can help slow ovarian cancer progression. However, more in-depth functional and clinical trials must be carried out to evaluate the suitability, safety, sensitivity, and specificity of these CSC-regulating miRNAs as prognostic biomarkers or therapeutic targets. [Display omitted]
Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of ovarian CSC is a critical factor that promotes treatment resistance and frequent relapse among ovarian cancer patients, leading to poor clinical outcomes. MicroRNA (miRNA) is a short, non-protein-coding RNA that regulates ovarian CSC development. Although multiple original research articles have discussed the CSC-regulatory roles of different miRNAs in ovarian cancer, there is a deficiency of a review article that can summarize the findings from different research papers. To narrow the gap in the literature, this review aimed to provide an up-to-date summary of the CSC-regulatory roles of various miRNAs in modulating ovarian cancer cell stemness. This review will begin by giving an overview of ovarian CSC and the pathways responsible for driving its appearance. Next, the CSC-regulatory roles of miRNAs in controlling ovarian CSC development will be discussed. Overall, more than 60 miRNAs have been reported to play CSC-regulatory roles in the development and progression of ovarian cancer. By targeting various downstream targets, these miRNAs can control the signaling activities of PI3K/AKT, EGFR/ERK, WNT/ß-catenin, NF-kß, Notch, Hippo/YAP, EMT, and DNA repair pathways. Hence, these CSC-modulatory miRNAs have the potential to be used as prognostic biomarkers in predicting the clinical outcomes of ovarian cancer patients. Targeting CSC-promoting miRNAs or increasing the expressions of CSC-repressing miRNAs can help slow ovarian cancer progression. However, more in-depth functional and clinical trials must be carried out to evaluate the suitability, safety, sensitivity, and specificity of these CSC-regulating miRNAs as prognostic biomarkers or therapeutic targets.Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of ovarian CSC is a critical factor that promotes treatment resistance and frequent relapse among ovarian cancer patients, leading to poor clinical outcomes. MicroRNA (miRNA) is a short, non-protein-coding RNA that regulates ovarian CSC development. Although multiple original research articles have discussed the CSC-regulatory roles of different miRNAs in ovarian cancer, there is a deficiency of a review article that can summarize the findings from different research papers. To narrow the gap in the literature, this review aimed to provide an up-to-date summary of the CSC-regulatory roles of various miRNAs in modulating ovarian cancer cell stemness. This review will begin by giving an overview of ovarian CSC and the pathways responsible for driving its appearance. Next, the CSC-regulatory roles of miRNAs in controlling ovarian CSC development will be discussed. Overall, more than 60 miRNAs have been reported to play CSC-regulatory roles in the development and progression of ovarian cancer. By targeting various downstream targets, these miRNAs can control the signaling activities of PI3K/AKT, EGFR/ERK, WNT/ß-catenin, NF-kß, Notch, Hippo/YAP, EMT, and DNA repair pathways. Hence, these CSC-modulatory miRNAs have the potential to be used as prognostic biomarkers in predicting the clinical outcomes of ovarian cancer patients. Targeting CSC-promoting miRNAs or increasing the expressions of CSC-repressing miRNAs can help slow ovarian cancer progression. However, more in-depth functional and clinical trials must be carried out to evaluate the suitability, safety, sensitivity, and specificity of these CSC-regulating miRNAs as prognostic biomarkers or therapeutic targets.
Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased self-renewability, aggression, metastatic potentials, and resistance to conventional anti-cancer therapy. The emergence of ovarian CSC is a critical factor that promotes treatment resistance and frequent relapse among ovarian cancer patients, leading to poor clinical outcomes. MicroRNA (miRNA) is a short, non-protein-coding RNA that regulates ovarian CSC development. Although multiple original research articles have discussed the CSC-regulatory roles of different miRNAs in ovarian cancer, there is a deficiency of a review article that can summarize the findings from different research papers. To narrow the gap in the literature, this review aimed to provide an up-to-date summary of the CSC-regulatory roles of various miRNAs in modulating ovarian cancer cell stemness. This review will begin by giving an overview of ovarian CSC and the pathways responsible for driving its appearance. Next, the CSC-regulatory roles of miRNAs in controlling ovarian CSC development will be discussed. Overall, more than 60 miRNAs have been reported to play CSC-regulatory roles in the development and progression of ovarian cancer. By targeting various downstream targets, these miRNAs can control the signaling activities of PI3K/AKT, EGFR/ERK, WNT/ß-catenin, NF-kß, Notch, Hippo/YAP, EMT, and DNA repair pathways. Hence, these CSC-modulatory miRNAs have the potential to be used as prognostic biomarkers in predicting the clinical outcomes of ovarian cancer patients. Targeting CSC-promoting miRNAs or increasing the expressions of CSC-repressing miRNAs can help slow ovarian cancer progression. However, more in-depth functional and clinical trials must be carried out to evaluate the suitability, safety, sensitivity, and specificity of these CSC-regulating miRNAs as prognostic biomarkers or therapeutic targets.
ArticleNumber 189191
Author Chong, Zhi-Xiong
Author_xml – sequence: 1
  givenname: Zhi-Xiong
  surname: Chong
  fullname: Chong, Zhi-Xiong
  email: zxchong@nus.edu.sg, zhixiong17c@yahoo.com
  organization: Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500 Semenyih, Selangor, Malaysia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39353485$$D View this record in MEDLINE/PubMed
BookMark eNqFkMtKxDAUQIMoOj6-QJAu3XTMzaPTLFyI-AJRGBTchSS9HTK0iSYdwb-3OurCha6yuOfcS84u2QwxICGHQKdAoTpZTq11JkwZZWIKtQIFG2QC9UyVTFawSSaUU1EKUE87ZDfnJaUgOa-2yQ5XXHJRywmR89hhLmJb9H5-d5YLH4qEi1VnBh8WRXw1yZtQjHccpiIP2AfMeZ9stabLePD17pHHy4uH8-vy9v7q5vzstnRcqqFsqaoAGdpGmYYKho1ARkHVTikhrbW1GOczUC0DBsbaqpnJWS0RXCWkQr5Hjtd7n1N8WWEedO-zw64zAeMqaw7AJHCqxIgefaEr22Ojn5PvTXrT318dAb4GXIo5J2x_EKD6I6he6s-g-iOoXgcdLfXLcn4Y28QwJOO7f9zTtYtjolePSWfncQzZ-IRu0E30f_rvak-P5w
CitedBy_id crossref_primary_10_1016_j_intimp_2025_114303
crossref_primary_10_3389_fonc_2024_1445502
Cites_doi 10.3724/abbs.2022159
10.1016/j.omto.2019.04.002
10.1016/j.molcel.2007.12.022
10.1038/sj.onc.1203219
10.18632/oncotarget.3862
10.1038/sj.cdd.4400663
10.1186/s40425-019-0666-1
10.1002/ijc.28086
10.1186/s12885-022-09999-y
10.1158/0008-5472.CAN-17-2020
10.1158/0008-5472.CAN-22-2213
10.1186/s13048-019-0588-z
10.1186/s13048-022-01014-z
10.1038/sj.onc.1207892
10.7150/jca.16723
10.1038/s41417-022-00574-y
10.1016/j.bbrc.2020.03.046
10.1038/s41598-022-18662-2
10.1016/j.omtn.2021.12.021
10.1101/gad.264929.115
10.1186/s12876-021-01962-8
10.1101/gad.1662308
10.1111/cpr.12038
10.1039/c2cs35146c
10.1186/1757-2215-6-50
10.1016/j.febslet.2014.01.058
10.1016/j.isci.2022.104159
10.3389/fonc.2021.632976
10.3389/fcell.2023.1057484
10.1016/j.dnarep.2022.103302
10.21037/atm-20-3749
10.1186/s43046-022-00143-2
10.1016/S1097-2765(00)80417-7
10.1016/j.stemcr.2018.12.002
10.1016/j.ncrna.2023.10.002
10.1158/0008-5472.CAN-20-1890
10.2147/CMAR.S180418
10.1186/s12935-018-0540-0
10.18632/oncotarget.4921
10.3892/ol.2017.5557
10.1159/000492260
10.3390/v14091952
10.1007/s00018-017-2656-0
10.1007/s13277-014-2527-3
10.1038/bjc.2014.105
10.1038/s41598-018-27021-z
10.3390/cancers12123765
10.7150/thno.29380
10.3390/ijms221910216
10.1016/j.omtn.2022.08.028
10.1016/j.canlet.2020.06.009
10.1016/j.bbrc.2020.04.076
10.1016/j.ygyno.2013.07.112
10.1016/j.canlet.2017.03.010
10.1158/0008-5472.CAN-20-2041
10.1016/j.molcel.2021.07.013
10.1016/j.ygyno.2011.03.026
10.1016/j.canlet.2016.11.017
10.1042/BSR20180922
10.1016/j.biopha.2020.109865
10.7554/eLife.66942
10.1038/s41598-023-45738-4
10.1038/labinvest.3780422
10.1038/aps.2010.56
10.1038/s41419-023-06028-z
10.1038/srep06413
10.1186/s12885-016-2904-y
10.1093/nar/gkad392
10.1186/s12943-020-1130-z
10.1038/onc.2017.185
10.1016/j.celrep.2022.110481
10.1016/j.gene.2016.12.030
10.1016/j.tranon.2021.101160
10.1186/s12957-021-02469-y
10.1186/s13062-021-00313-7
10.21037/cco-20-34
10.3390/ijms20205168
10.1038/oncsis.2017.25
10.1080/21655979.2021.2022267
10.1038/s41388-018-0601-9
10.3346/jkms.2016.31.6.836
10.1073/pnas.0703820104
10.1186/s12929-022-00860-9
10.1007/s43032-021-00717-w
10.1053/j.gastro.2005.02.067
10.1016/j.omto.2018.12.011
10.1016/j.ccr.2012.12.020
10.7150/jca.58593
10.1038/s41416-020-0825-7
10.1007/s11010-022-04507-z
10.1186/s12943-018-0782-4
10.3892/mmr.2020.11236
10.1038/srep37652
10.1186/s13046-022-02553-5
10.1186/1757-2215-6-18
10.1002/path.5356
10.1038/onc.2010.111
10.1038/s41392-021-00791-1
10.1074/jbc.M106157200
10.3892/or.2017.5583
10.3892/mmr.2020.11767
10.1016/j.semcdb.2021.11.003
10.3390/cimb43020044
10.1016/j.omto.2019.10.008
10.1155/2021/8842554
10.1186/s41544-019-0024-y
10.1016/S0092-8674(02)00966-2
10.1186/s13048-017-0306-7
10.1186/s13046-016-0415-y
10.18632/oncotarget.14123
10.1016/j.bbrc.2017.04.008
10.1158/0008-5472.CAN-18-3668
10.3390/genes12020269
10.1016/j.gene.2024.148738
10.1016/j.ncrna.2024.06.012
10.1016/j.immuni.2013.08.025
10.1111/cas.15100
10.31557/APJCP.2021.22.11.3525
10.3390/genes14020314
10.3390/biom13050871
10.1038/nm.2284
10.1186/s12885-022-09837-1
10.1007/s11064-022-03833-4
10.1159/000491526
10.1007/s12253-018-0453-1
10.7150/jca.20348
10.1158/0008-5472.CAN-16-1115
10.3390/cancers14205093
10.1038/s41598-020-70948-5
10.7150/jca.87692
10.3390/cancers12040856
10.1097/IGC.0000000000001023
10.1038/bjc.2016.379
10.3390/ijms241210337
10.1016/j.jbc.2022.102796
10.3390/mps4010010
10.2147/OTT.S136549
10.1016/j.molonc.2015.01.007
10.3390/ijms232415900
10.1186/s13048-018-0439-3
10.1016/j.yexcr.2019.06.007
10.1080/17460441.2020.1765770
10.1002/1878-0261.12762
10.1097/01.JTO.0000361752.86918.09
10.1016/S0092-8674(00)81780-8
10.1186/s13287-023-03244-4
10.18632/oncotarget.11920
10.1016/j.biopha.2018.03.018
10.1038/s41388-021-01913-3
10.3390/ijms231710064
10.18632/oncotarget.127
10.1371/annotation/ee15c511-4f60-4415-a0f4-c99dcf1bb2e2
10.1111/cpr.13582
10.1038/s41598-018-30978-6
10.1186/s13048-024-01429-w
10.1038/srep34730
10.1007/s13277-014-2790-3
10.1186/s12885-019-5824-9
10.34172/apb.2020.076
10.1038/ncomms6370
10.1111/cas.13186
10.1016/j.celrep.2017.02.016
10.1038/s41467-023-40213-0
10.1002/hed.27155
10.1073/pnas.1419599111
10.3389/fonc.2024.1320887
10.18632/oncotarget.11454
10.1016/0092-8674(93)80048-J
10.1186/s13048-018-0403-2
10.1186/s12967-020-02243-w
10.1371/journal.pone.0158946
10.1371/journal.pone.0221679
10.3390/cells6020013
10.3390/cancers10080272
10.1038/onc.2012.275
10.3892/or.2017.5938
10.3233/CBM-182182
10.1016/j.bbrc.2018.05.018
10.1038/s41419-021-03844-z
10.3390/ijms23137167
10.1038/onc.2017.33
10.1038/s41392-022-00934-y
10.7150/jca.95852
10.1016/j.tibs.2004.11.009
10.1007/s00018-023-05036-8
10.1186/s40064-016-2660-0
10.1186/s13048-022-00981-7
10.1186/s13048-020-00618-7
10.1007/s12672-023-00846-5
10.1016/j.tranon.2022.101578
10.1038/s41419-023-06076-5
10.1158/2159-8290.CD-13-0159
10.1101/gad.1843810
10.1186/s13578-021-00539-y
10.1186/s13048-021-00917-7
10.1038/s41419-023-05651-0
10.18632/oncotarget.3220
10.4161/15384101.2014.994966
10.1016/j.oraloncology.2010.12.001
10.3390/cancers13164178
10.1007/s12672-023-00674-7
10.1074/jbc.M610054200
10.1080/15384047.2019.1579960
10.1158/0008-5472.CAN-04-3931
10.1186/s12935-016-0376-4
10.1186/s13062-023-00449-8
10.1161/HYPERTENSIONAHA.120.16900
10.1177/1753425919840702
10.1186/s11658-023-00471-8
10.1586/14760584.2015.979798
10.1038/s41598-022-19290-6
10.3892/or.2021.8014
10.1186/s13046-019-1179-y
10.1186/bcr3447
10.1038/s41388-021-02014-x
10.3892/or.2016.4591
10.1016/j.devcel.2019.04.010
10.1016/j.ajpath.2011.11.015
10.1038/s41420-024-01858-y
10.1038/bjc.2017.335
10.1186/1471-2407-14-85
10.1057/s41599-022-01147-y
10.2147/IJWH.S197604
10.18632/oncotarget.11495
ContentType Journal Article
Copyright 2024 Elsevier B.V.
Copyright © 2024 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2024 Elsevier B.V.
– notice: Copyright © 2024 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.bbcan.2024.189191
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1879-2561
ExternalDocumentID 39353485
10_1016_j_bbcan_2024_189191
S0304419X24001227
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
ABBQC
ABEFU
ABFNM
ABGSF
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACIUM
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEKER
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HLW
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LX3
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SAE
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UQL
WUQ
XJT
XPP
ZE2
~G-
AATTM
AAYWO
AAYXX
ACIEU
ACVFH
ADCNI
AEIPS
AEUPX
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
CITATION
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ID FETCH-LOGICAL-c359t-f0961e2ebd9ad042ed4e20198c9945bbb8461e719f2121abb6d75785e1c6459e3
IEDL.DBID .~1
ISSN 0304-419X
1879-2561
IngestDate Sun Aug 24 03:59:15 EDT 2025
Mon Jul 21 06:03:22 EDT 2025
Thu Apr 24 23:11:43 EDT 2025
Tue Jul 01 00:21:57 EDT 2025
Sat Dec 21 16:01:32 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords NRP2
ZEB1/2
CDC
MDSC
JNK
WWC1
PTEN
CDK
TAZ
AREG
ERBB
SLUG
Ovarian cancer
MYLK
FOXQ1
MAML
OCT4
TMEM100
DNMT
UTR
PI3K
ALDH1
CtBP2
LATS
mTOR
GPR137
AML
NOD
CML
FGF
MST1
PTPN
BCL
ARID1A
ADAR2
DKK1
EMT
DDB2
IκBα
ADAM19
MEK
NA
SCNN1D
TBL1XR1
PIP3
PTPLAD2
DOCK1
PIP2
ABCG2
ERK
GAS7
HDAC
Prognostic biomarkers
lncRNA
miRNAs
LRP5
RTK
SAV
XIAP
YAP
LKB1
SCID
EGFR
SOCS3
CSC
miRNA
CSL
WAF1
SNAIL
CD
EGR1
NF-kß
HIF
CMTM4
GSK-3ß
VEGF
MYPT1
STAT3
IKK
HMGA2
RAB27A
AKT
KLF4
S100B
Therapeutic agents
DLG2
PAR2
MOB1
SP1
SFRP
NICD
BAX
NANOG
HOXD9
SOX
Language English
License Copyright © 2024 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c359t-f0961e2ebd9ad042ed4e20198c9945bbb8461e719f2121abb6d75785e1c6459e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 39353485
PQID 3112513094
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3112513094
pubmed_primary_39353485
crossref_primary_10_1016_j_bbcan_2024_189191
crossref_citationtrail_10_1016_j_bbcan_2024_189191
elsevier_sciencedirect_doi_10_1016_j_bbcan_2024_189191
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2024
2024-11-00
20241101
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. Reviews on cancer
PublicationTitleAlternate Biochim Biophys Acta Rev Cancer
PublicationYear 2024
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Rizzolio, Battistini, Cagnoni, Apicella, Vella, Giordano, Tamagnone (bb0390) 2018; 78
Brou, Logeat, Gupta, Bessia, Lebail, Doedens, Cumano, Roux, Black, Israë (bb0515) 2000; 5
Han, Zhou, Li, Qin, Chen, Liu (bb1070) 2017; 38
Liu, Kelnar, Liu, Chen, Calhoun-Davis, Li, Patrawala, Yan, Jeter, Honorio, Wiggins, Bader, Fagin (bb0970) 2011; 17
Zhang, Zhu, He, Dong (bb1300) 2024; 17
Kearney, Norris, Ghomlaghi, Wong, Humphrey, Carroll, Yang, Cooke, Yang, Geddes, Shin, Fazakerley, Nguyen, James, Burchfield (bb0280) 2021; 10
Zhu, Wang, Zhang, Wang, Li, Yao, Mei, Zhang (bb0385) 2014; 588
Hojo, Huisken, Wang, Chirshev, Kim, Nguyen, Campos, Glackin, Ioffe, Unternaehrer (bb0470) 2018; 8
Wang, Yo, Lee, Liao, Chao, Su, Lai (bb0170) 2012; 180
Gareev, Beylerli, Tamrazov, Ilyasova, Shumadalova, Du, Yang (bb1170) 2023; 8
Zhang, Powell, Li (bb0150) 2020; 12
Kikuchi, Matsumoto, Sada (bb0450) 2022; 125
Huang, Zhao, Weng, He, Wu, Fu, Sui, Ma, Liu (bb0815) 2017; 486
Li, Mizukami, Zhang, Jo, Chung (bb0300) 2005; 128
Wan, Wang, Li, Wang, Zhang (bb0325) 2022; 54
Li, Chen, Yuan, Chen, Zhong, Teng, Xu, Qiu, Cao (bb0465) 2019; 12
Srivastava, Banerjee, Cui, Han, Cai, Liu, Wu, Cui, Li, Zhang, Xie, Selvendiran, Patnaik, Karpf, Liu, Cohn, Wang (bb0105) 2019; 79
Dai, Zhang, Zhu, Shan, Chen (bb0670) 2013; 131
Roberts, Tran, Pitruzzello, Wen, Loeza, Dellinger, Mor, Glackin (bb0475) 2016; 6
Cho, Kim, Lee, Jeong, Yun, Choi, Jeong, Chang, Oh, Yoo, Lee, Yoon, Lee, Park, Jung, Kim, Kim, Suh, Choi, Choi, Kim, Kwon (bb0605) 2022; 29
Liu, Nenutil, Appleyard, Murray, Boylan, Thompson, Coates (bb0155) 2014; 110
Yeh, Chuang, Chao, Wang (bb0260) 2013; 133
Li, Tang, Cao, Xu, Xu, Lin, Tang (bb0580) 2024; 19
Xiong, Fu, Yu, He (bb1210) 2023; 14
Ishida, Selaru (bb1245) 2013; 1
Gilson, Drouot, Witz, Merlin, Becuwe, Harlé (bb0590) 2019; 20
Chen, Suen, Gu, Li, Chan (bb0865) 2014; 4
Kaipio, Chen, Roering, Huhtinen, Mikkonen, Östling, Lehtinen, Mansuri, Korpela, Potdar, Hynninen, Auranen, Grénman, Wennerberg, Hautaniemi, Carpén (bb0165) 2020; 250
.
Tang, Fan, You, Huang, Kang, Huang, Huang, Chang, Cheng (bb1055) 2022; 23
S.K.Y. To, Mak, Eva Fung, Che, Li, Deng, Ru, Zhang, A.S.T. (bb0980) 2017; 36
Li, Kong, Cong, Ma, Wang, Ma (bb0900) 2023; 14
Ho, Clark, Le (bb1240) 2022; 23
Luyao, Zhi Xiaogai, Yingying, Ziyi, Cao Jian, Sujuan, Hongjie (bb0080) 2020; 306
Song, Liao, Yao, Xu, Shen, Tian, Wang, Xing (bb0455) 2023; 30
Chang, Liu, Huang, Qin, Yang, Chen (bb0100) 2017; 605
Ginnavaram, Vasugi, Sundaram (bb0235) 2023; 15
Kwon, Factora, Dey, Kota (bb0985) 2019; 12
Jang, Kang, Han, Kim, Cho (bb1080) 2024; 10
Zhuang, Bai, Liu (bb0620) 2019; 20
Jin, Wang, Meng, Du, Li, Zhang, Zhou, Fu (bb0855) 2016; 16
Cui, Liu, Zhou, Wang, Zhang, Ye (bb0745) 2010; 31
Chen, Luo, Hu, Li, Zhang (bb0975) 2018; 47
Li, Xu, Liu, Xi, Wang, Wu, Li (bb0755) 2021; 9
Jia, Wei, Liu, Zhao (bb0765) 2016; 31
Liu, Du, Zhou, Xu, Chen, Chen, Yang, Liu, Shao, Zhang, Yu, Xie, Guan, Liu (bb0945) 2018; 8
Zhang, Yang, Cui, Zhang (bb1065) 2022; 27
Peng, Shi, Feng, Wei, Yin (bb1090) 2019; 25
Li, Chen, Zeng, Wan, Duan, Jiang (bb1225) 2017; 116
Chatterjee, Bose, Singh, Dixit, Puia, Srivastava (bb0760) 2024; 9
Ni, Chen, Ling, Wu, Ren, Zhu (bb0060) 2020; 22
Liu, Fu, Zhang, Zhang, Liang, Li, Li, Sui, Jiang, Lu, Zhao, Dionigi, Sun (bb0725) 2019; 15
Chikuda, Otsuka, Shimomura, Ito, Miyazaki, Takahashi, Nagasaki, Mukudai, Ochiya, Shimane, Shirota, Yamamoto (bb0775) 2020; 12
Purba, Saita, Maruyama (bb0350) 2017; 6
Nandy, Orozco, Lopez-Valdez, Rene Roberts, Subramani, Arumugam, Dwivedi, Stewart, Prabhakar, Jones (bb1050) 2017; 117
Cha, Y. ho Choi, Hwang, Jeong, An (bb0340) 2017; 8
Bourguignon, Gilad, Peyrollier (bb0360) 2007; 282
Luo, Dong, Chen, Yang, Lai (bb0085) 2013; 46
Pal, Jaiswar, Dwivedi, Tripathi, Dwivedi, Sankhwar (bb1140) 2015; 12
Yang, Li, Yu, Yang, Cai, Chen (bb1130) 2018; 38
Huang, Wang, Liu, Li (bb0780) 2019; 17
Wu, Liu, Zhu, Lei, Wu, Zhang, Ye, Cao, He (bb0630) 2015; 6
Dong, Xiong, Watari, Hanley, Konno, Ihira, Yamada, Kudo, Yue, Sakuragi (bb0965) 2016; 35
Lin, Ding (bb0190) 2017; 17
Deng, Bai, Feng, Ni, Beretov, Graham, Li (bb0265) 2019; 19
Lau, So, Leung (bb0365) 2013; 8
Howard, Stephen, Bou, Lirette, Antonio, Antonio, Jagan, Paolo (bb0035) 2021; 7
Rössig, Badorff, Holzmann, Zeiher, Dimmeler (bb0285) 2002; 277
Kenda Suster, Smrkolj, Virant-Klun (bb0135) 2017; 10
Li, Zhang, Peng, Jiang, Liu, Tian, Hou, Xie, Peng, Zhou (bb0825) 2022; 13
Mogler, Kamrud (bb1165) 2015; 14
Suster, Virant-Klun (bb0040) 2019; 11
Keane, de Weerd, Ejeskär (bb0595) 2022; 112
Yang, Sun, Hu, Zheng, Ji, Pecot, Zhao, Reynolds, Cheng, Rupaimoole, Cogdell, Nykter, Broaddus, Rodriguez-Aguayo, Lopez-Berestein, Liu, Shmulevich, Sood, Chen, Zhang (bb1195) 2013; 23
Stephenson, Taggart, Xu, Fowler, Wu, Suo (bb0490) 2023; 299
Seok, Lee, Jang, Chi (bb1265) 2018; 75
Christensen, Larsen, Kauppinen, Schratt (bb1160) 2010; 3
Li, Cen, Huang, Chen, Chen, Pang, Fu, He, Ji (bb1200) 2021; 41
Nam, Lee, Yim, Kim, Kim, Kim, Kim (bb0070) 2012; 5
Muñoz-Galván, Felipe-Abrio, Verdugo-Sivianes, Perez, Jiménez-García, Suarez-Martinez, Estevez-Garcia, Carnero (bb0575) 2020; 19
Bapat, Mali, Koppikar, Kurrey (bb0125) 2005; 65
Tsai, Lai, Manne, Tsai, Sarbassov, Lin (bb0290) 2022; 29
Yang, Yan, Liu, Jiang, Hou (bb0205) 2017; 10
Lytle, Yario, Steitz (bb0055) 2007; 104
Wang, Hung, Wu, Lo, Da Chen, Chen, Hsieh, Hu, Hou, Yuan (bb1000) 2022; 12
Li, Liu, Zhao, Wang, Gu, Shen, Li, Wang, Li (bb0790) 2020; 19
Zheng, Chen, Zhang (bb0540) 2022; 13
Gao, Foster, Yang, Feng, Shen, Mankin, Hornicek, Amiji, Duan (bb0185) 2015; 6
Xiao, Liu, Zhang, Qiu, Huang, Zhang, Chen, Ling, Liu, Zhang (bb0715) 2021; 12
Kang, Zhang, Zhang, Sun (bb0400) 2021; 13
Cui, Chang, Fang, Du, Wu, Wang, Liu, Luo (bb0835) 2019; 25
Roostaie, Esmaily, Javanshir, Arabi, Tafti, Bereimipour, Mahmoodzadeh, Hadjilooei, Hosseininejad (bb1035) 2023; 2
Zhang, Cui, Lai, Liu, Ghia, Widhopf, Zhang, Wu, Chen, Wu, Schwab, Carson, Kipps (bb0120) 2014; 111
Dasgupta, Chatterjee (bb1155) 2021; 4
Shimada, Yabuki, Noguchi, Tsuchida, Komatsu, Hamano, Yamada, Ezaki, Hirata, Matsuzawa (bb1060) 2022; 23
Yu, Chen, Chiou, Tsai, Huang, Chang, Tseng, Chiou, Yen, Chou, Chu, Lo (bb1010) 2011; 47
Sihombing, Andrijono, Purwoto, Gandamihardja, Harahap, Rustamadji, Kekalih, Widyawati, Fuady (bb0180) 2022; 34
Virant-Klun, Stimpfel (bb0130) 2016; 6
Baumann, Winkler (bb1250) 2014; 6
Zhou, Chen, Song, Tao, Yang, Zuo (bb0215) 2015; 8
Shen, Jin, Fang, Chen (bb0940) 2023; 28
Yin, Chen, Alvero, Fu, Holmberg, Glackin, Rutherford, Mor (bb0860) 2010; 29
Zhang, Ma, Xue, Wang, Chen, Li, Li, Hu, Zhao, Zhou (bb0700) 2024; 81
Guo Rongjao, Qiuhua, Yifeng (bb1125) 2010; 25
Faoro, Cervantes, El-Hashani, Salgia (bb0695) 2010; 4
Wang, Li, Zhu, Hong, Hu, Wang, Cui, Hao (bb0710) 2021; 14
Wang, Cho, Yoo, Jung, Kim, Kim, Lee, Jo, Han, Song, Lee, Kim, Lee, Ku, Lee, Song (bb0425) 2022; 12
Park, Jeong, Lee, Kim, Kim, Kwon, Lee, Kim, An (bb1115) 2013; 6
Momenimovahed, Tiznobaik, Taheri, Salehiniya (bb0010) 2019; 11
Ikram, Masadah, Nelwan, Zainuddin, Ghaznawie, Wahid (bb0210) 2021; 22
Sudha (bb0440) 2013; 21
Chen, Zhang, Wang, Chen, Yang, Cai, Wang, Shi, Dou (bb0640) 2013; 6
Iacomino (bb1235) 2023; 14
Cheng, Ye, Dai, Sun (bb0460) 2021; 14
Sazonova, Petrichuk, Kopeina, Zhivotovsky (bb0585) 2021; 16
Liu, Ning, Yi, Yuan, Fang, Lin, Zeng (bb0065) 2020; 125
Liu, Ma, Sun, Yu, Wang (bb0375) 2021; 12
Frisk, Sørensen, Pedersen, Dalgaard (bb0090) 2023; 13
Kobayashi, Sawada, Miyamoto, Shimizu, Yamamoto, Kinose, Nakamura, Kawano, Kodama, Hashimoto, Kimura (bb1215) 2020; 527
Shnaider, Petrushanko, Aleshikova, Babaeva, Ashrafyan, Borovkova, Dobrokhotova, Borovkov, Shender, Khomyakova (bb0200) 2023; 11
Yang, Cheng, You, Yan, Liu, Li (bb0610) 2018; 40
Bug, Tishkov, Moiseev, Petukhova (bb0625) 2021; 43
Nishimura, Jung, Shah, Lu, Spizzo, Shimizu, Han, Ivan, Rossi, Zhang, Nicoloso, Wu, Almeida, Bottsford-Miller, Pecot, Zand, Matsuo, Shahzad, Jennings, Rodriguez-Aguayo, Lopez-Berestein, Sood, Calin (bb1190) 2013; 3
Liu, Qin, Hou, Huang (bb0645) 2015; 36
Ysrafil, Astuti, Anwar, Martien, Sumadi, Wardhana, Haryana (bb1205) 2020; 10
Cai, Deng, Zhou, Cai, Chen (bb1075) 2021; 21
Liu, Ma, Liu, Xiao, Pan, Zhou, Jia (bb0675) 2019; 38
Fu, Chen, Xu, Lin, Wen, Chen, Pan (bb0925) 2022; 17
Xu, Zhu, Chen, Huang, Ai, Wu, Zhang, Zhao (bb0950) 2018; 18
Gartel, Tyner (bb0615) 2002; 1
Padthaisong, Thanee, Namwat, Phetcharaburanin, Klanrit, Khuntikeo, Titapun, Sungkhamanon, Saya, Loilome (bb0175) 2020; 18
Lu, Kang (bb0935) 2019; 49
Zhou, Lin, Long, Yang, Zhang, Wu, Chu (bb0510) 2022; 7
Jennifer, Gail (bb0370) 2011; 2
Chen, Hou, Tang, Liu, Chen, Zhang, Wang (bb0870) 2021; 41
Jeong, Kang, Kim, Kim, Heo, Kwon, Kim, Jung, An (bb0635) 2017; 386
Sohn (bb0770) 2022; 15
E. Aparicio-Puerta, P. Hirsch, G.P. Schmartz, F. Kern, T. Fehlmann, A. Keller, MiEAA 2023: Updates, new functional microRNA sets and improved enrichment visualizations, Nucleic Acids Res. 51 (2023) W319–W325. doi
Chirshev, Hojo, Bertucci, Sanderman, Nguyen, Wang, Suzuki, Brito, Martinez, Castañón, Mirshahidi, Vazquez, Wat, Oberg, Ioffe, Unternaehrer (bb0850) 2020; 14
Krivdova, Voisin, Schoof, Marhon, Murison, McLeod, Gabra, Zeng, Aigner, Yee, Shishkin, Van Nostrand, Hermans, Trotman-Grant, Mbong, Kennedy, Gan, Wagenblast, De Carvalho, Salmena, Minden, Bader, Yeo, Dick, Lechman (bb1085) 2022; 38
Ling, Wen, Chen, Xiong, Liu, Chen, Liu, Zhang (bb0110) 2023; 14
Chen, Zhang, Bai, Liu (bb0380) 2022; 22
Jäger, Schubert, Ochrimenko, Fischer, Schubert (bb1185) 2012; 41
Cui, Kryczek, Zhao, Zhao, Kuick, Roh, Vatan, Szeliga, Mao, Thomas, Kotarski, Tarkowski, Wicha, Cho, Giordano, Liu, Zou (bb1120) 2013; 39
Park, Hwang, Jeong, Jung, Choi, Joo, Song, Lee, An (bb1025) 2020; 13
Nowicki, Kulus, Wieczorkiewicz, Pieńkowski, Stefańska, Skupin-Mrugalska, Bryl, Mozdziak, Kempisty, Piotrowska-Kempisty (bb1110) 2021; 13
Wang, Liu, Dou, Zhang, Yang (bb0535) 2021; 112
Dong, Yeo, Lopez, Zhang, Dankert Eggum, Rokita, Ung, Levee, Her, Howe, Hou, van Ree, Li, He, Tao, Fritchie, Torres-Mora, Lehman, Meves, Razidlo, Rathi, Weroha, Look, van Deursen, Li, Westendorf, Maris, Zhu (bb1095) 2021; 81
Qiu, Zhang, Yu, Wang, Jia, Wang (bb1005) 2018; 8
N
Hojo (10.1016/j.bbcan.2024.189191_bb0470) 2018; 8
Kearney (10.1016/j.bbcan.2024.189191_bb0280) 2021; 10
Chao (10.1016/j.bbcan.2024.189191_bb0880) 2023; 478
Liu (10.1016/j.bbcan.2024.189191_bb0250) 2021; 11
Yang (10.1016/j.bbcan.2024.189191_bb1195) 2013; 23
Yuan (10.1016/j.bbcan.2024.189191_bb0655) 2019; 24
Dasgupta (10.1016/j.bbcan.2024.189191_bb1155) 2021; 4
Shi (10.1016/j.bbcan.2024.189191_bb0480) 2023; 24
Wang (10.1016/j.bbcan.2024.189191_bb1000) 2022; 12
Li (10.1016/j.bbcan.2024.189191_bb0570) 2015; 9
Bug (10.1016/j.bbcan.2024.189191_bb0625) 2021; 43
Gareev (10.1016/j.bbcan.2024.189191_bb1170) 2023; 8
Suster (10.1016/j.bbcan.2024.189191_bb0040) 2019; 11
Cittelly (10.1016/j.bbcan.2024.189191_bb0990) 2013; 32
Lobello (10.1016/j.bbcan.2024.189191_bb1135) 2016; 7
Ling (10.1016/j.bbcan.2024.189191_bb0110) 2023; 14
Jennifer (10.1016/j.bbcan.2024.189191_bb0370) 2011; 2
Gao (10.1016/j.bbcan.2024.189191_bb0185) 2015; 6
Bolós (10.1016/j.bbcan.2024.189191_bb0520) 2013; 15
Zhuang (10.1016/j.bbcan.2024.189191_bb0620) 2019; 20
Li (10.1016/j.bbcan.2024.189191_bb0315) 2021; 40
Pan (10.1016/j.bbcan.2024.189191_bb1100) 2024; 927
Ling (10.1016/j.bbcan.2024.189191_bb0220) 2018; 11
Nandy (10.1016/j.bbcan.2024.189191_bb1050) 2017; 117
Lee (10.1016/j.bbcan.2024.189191_bb0345) 2020; 526
Nishimura (10.1016/j.bbcan.2024.189191_bb1190) 2013; 3
Wu (10.1016/j.bbcan.2024.189191_bb0955) 2011; 122
Orso (10.1016/j.bbcan.2024.189191_bb0875) 2023; 42
Li (10.1016/j.bbcan.2024.189191_bb0790) 2020; 19
Park (10.1016/j.bbcan.2024.189191_bb1025) 2020; 13
Dan (10.1016/j.bbcan.2024.189191_bb0500) 2008; 22
Wang (10.1016/j.bbcan.2024.189191_bb0535) 2021; 112
Purba (10.1016/j.bbcan.2024.189191_bb0350) 2017; 6
Chen (10.1016/j.bbcan.2024.189191_bb0870) 2021; 41
Feng (10.1016/j.bbcan.2024.189191_bb0505) 2016; 7
Chen (10.1016/j.bbcan.2024.189191_bb0975) 2018; 47
Zhang (10.1016/j.bbcan.2024.189191_bb1300) 2024; 17
Sihombing (10.1016/j.bbcan.2024.189191_bb0180) 2022; 34
Lytle (10.1016/j.bbcan.2024.189191_bb0055) 2007; 104
Yu (10.1016/j.bbcan.2024.189191_bb1010) 2011; 47
Chen (10.1016/j.bbcan.2024.189191_bb0660) 2017; 8
Ni (10.1016/j.bbcan.2024.189191_bb0550) 2015; 29
Muñoz-Galván (10.1016/j.bbcan.2024.189191_bb0575) 2020; 19
Lau (10.1016/j.bbcan.2024.189191_bb0365) 2013; 8
Yang (10.1016/j.bbcan.2024.189191_bb0565) 2021; 2021
Ysrafil (10.1016/j.bbcan.2024.189191_bb1205) 2020; 10
Li (10.1016/j.bbcan.2024.189191_bb0405) 2020
Levy (10.1016/j.bbcan.2024.189191_bb0555) 2008; 29
Junk (10.1016/j.bbcan.2024.189191_bb0930) 2017; 36
Yin (10.1016/j.bbcan.2024.189191_bb0860) 2010; 29
Deng (10.1016/j.bbcan.2024.189191_bb0265) 2019; 19
Roostaie (10.1016/j.bbcan.2024.189191_bb1035) 2023; 2
Zheng (10.1016/j.bbcan.2024.189191_bb0540) 2022; 13
Raghavan (10.1016/j.bbcan.2024.189191_bb0145) 2019; 7
Yang (10.1016/j.bbcan.2024.189191_bb1130) 2018; 38
Zhang (10.1016/j.bbcan.2024.189191_bb0120) 2014; 111
Liu (10.1016/j.bbcan.2024.189191_bb0155) 2014; 110
Belur Nagaraj (10.1016/j.bbcan.2024.189191_bb0685) 2019; 12
Chen (10.1016/j.bbcan.2024.189191_bb0820) 2017; 77
Chatterjee (10.1016/j.bbcan.2024.189191_bb0760) 2024; 9
Nowicki (10.1016/j.bbcan.2024.189191_bb1110) 2021; 13
Kwon (10.1016/j.bbcan.2024.189191_bb0985) 2019; 12
Brou (10.1016/j.bbcan.2024.189191_bb0515) 2000; 5
Wang (10.1016/j.bbcan.2024.189191_bb0710) 2021; 14
Raugh (10.1016/j.bbcan.2024.189191_bb0735) 2023; 13
Lu (10.1016/j.bbcan.2024.189191_bb1045) 2020; 8
Kalantari (10.1016/j.bbcan.2024.189191_bb0160) 2022; 20
Cha (10.1016/j.bbcan.2024.189191_bb0340) 2017; 8
Cho (10.1016/j.bbcan.2024.189191_bb0605) 2022; 29
Li (10.1016/j.bbcan.2024.189191_bb1225) 2017; 116
Wang (10.1016/j.bbcan.2024.189191_bb0530) 2021; 77
Tung (10.1016/j.bbcan.2024.189191_bb0115) 2017; 6
Rizzolio (10.1016/j.bbcan.2024.189191_bb0390) 2018; 78
Wu (10.1016/j.bbcan.2024.189191_bb0630) 2015; 6
Li (10.1016/j.bbcan.2024.189191_bb0900) 2023; 14
Ni (10.1016/j.bbcan.2024.189191_bb0060) 2020; 22
Ma (10.1016/j.bbcan.2024.189191_bb0030) 2023; 14
Ortiz (10.1016/j.bbcan.2024.189191_bb0015) 2022; 5
Li (10.1016/j.bbcan.2024.189191_bb0825) 2022; 13
Domanegg (10.1016/j.bbcan.2024.189191_bb0395) 2022; 14
Li (10.1016/j.bbcan.2024.189191_bb0905) 2020; 490
Tan (10.1016/j.bbcan.2024.189191_bb0750) 2014; 35
Segal (10.1016/j.bbcan.2024.189191_bb1270) 2020; 15
10.1016/j.bbcan.2024.189191_bb0050
Zhao (10.1016/j.bbcan.2024.189191_bb0225) 2021; 23
Zhang (10.1016/j.bbcan.2024.189191_bb1065) 2022; 27
Shnaider (10.1016/j.bbcan.2024.189191_bb0200) 2023; 11
Ruan (10.1016/j.bbcan.2024.189191_bb0240) 2019; 11
Vuk (10.1016/j.bbcan.2024.189191_bb0320) 1998; 95
Han (10.1016/j.bbcan.2024.189191_bb0915) 2023; 14
Rössig (10.1016/j.bbcan.2024.189191_bb0285) 2002; 277
Lu (10.1016/j.bbcan.2024.189191_bb0960) 2014; 14
Kobayashi (10.1016/j.bbcan.2024.189191_bb1215) 2020; 527
Faoro (10.1016/j.bbcan.2024.189191_bb0695) 2010; 4
El Helou (10.1016/j.bbcan.2024.189191_bb0890) 2017; 18
Wang (10.1016/j.bbcan.2024.189191_bb0170) 2012; 180
Baumann (10.1016/j.bbcan.2024.189191_bb1250) 2014; 6
Ikram (10.1016/j.bbcan.2024.189191_bb0210) 2021; 22
Scholz (10.1016/j.bbcan.2024.189191_bb1180) 2022; 14
Keane (10.1016/j.bbcan.2024.189191_bb0595) 2022; 112
Huang (10.1016/j.bbcan.2024.189191_bb0780) 2019; 17
Zhu (10.1016/j.bbcan.2024.189191_bb0385) 2014; 588
Li (10.1016/j.bbcan.2024.189191_bb0580) 2024; 19
Bourguignon (10.1016/j.bbcan.2024.189191_bb0360) 2007; 282
Sohn (10.1016/j.bbcan.2024.189191_bb0770) 2022; 15
Xiao (10.1016/j.bbcan.2024.189191_bb0715) 2021; 12
Hu (10.1016/j.bbcan.2024.189191_bb0830) 2021; 6
Deshmukh (10.1016/j.bbcan.2024.189191_bb0995) 2017; 396
Kong (10.1016/j.bbcan.2024.189191_bb1030) 2018; 501
Sudha (10.1016/j.bbcan.2024.189191_bb0440) 2013; 21
Heald (10.1016/j.bbcan.2024.189191_bb0600) 1993; 74
Martins (10.1016/j.bbcan.2024.189191_bb0730) 2021; 22
S.K.Y. To (10.1016/j.bbcan.2024.189191_bb0980) 2017; 36
Liu (10.1016/j.bbcan.2024.189191_bb0675) 2019; 38
Kenda Suster (10.1016/j.bbcan.2024.189191_bb0135) 2017; 10
Christensen (10.1016/j.bbcan.2024.189191_bb1160) 2010; 3
Dai (10.1016/j.bbcan.2024.189191_bb0670) 2013; 131
Liu (10.1016/j.bbcan.2024.189191_bb0970) 2011; 17
Ishida (10.1016/j.bbcan.2024.189191_bb1245) 2013; 1
Shan (10.1016/j.bbcan.2024.189191_bb0885) 2022; 15
Kang (10.1016/j.bbcan.2024.189191_bb0400) 2021; 13
Zeh (10.1016/j.bbcan.2024.189191_bb1220) 2019; 14
Chikuda (10.1016/j.bbcan.2024.189191_bb0775) 2020; 12
Wen (10.1016/j.bbcan.2024.189191_bb0245) 2017; 108
Zhou (10.1016/j.bbcan.2024.189191_bb0310) 2023; 14
Yang (10.1016/j.bbcan.2024.189191_bb0610) 2018; 40
Chen (10.1016/j.bbcan.2024.189191_bb0640) 2013; 6
Canesin (10.1016/j.bbcan.2024.189191_bb0805) 2020; 10
Mansoori (10.1016/j.bbcan.2024.189191_bb0840) 2021; 12
Jäger (10.1016/j.bbcan.2024.189191_bb1185) 2012; 41
Virant-Klun (10.1016/j.bbcan.2024.189191_bb0130) 2016; 6
Parte (10.1016/j.bbcan.2024.189191_bb0140) 2018; 11
Lin (10.1016/j.bbcan.2024.189191_bb0810) 2018; 10
Chang (10.1016/j.bbcan.2024.189191_bb0100) 2017; 605
Wang (10.1016/j.bbcan.2024.189191_bb0425) 2022; 12
Iwasa (10.1016/j.bbcan.2024.189191_bb0330) 2023; 48
Michael (10.1016/j.bbcan.2024.189191_bb0420) 2021; 81
Liu (10.1016/j.bbcan.2024.189191_bb0725) 2019; 15
Gaona-Luviano (10.1016/j.bbcan.2024.189191_bb0005) 2020; 9
Roberts (10.1016/j.bbcan.2024.189191_bb0475) 2016; 6
Chirshev (10.1016/j.bbcan.2024.189191_bb0850) 2020; 14
Ye (10.1016/j.bbcan.2024.189191_bb0720) 2023; 27
Giornelli (10.1016/j.bbcan.2024.189191_bb0020) 2016; 5
Liu (10.1016/j.bbcan.2024.189191_bb0895) 2023; 14
Cui (10.1016/j.bbcan.2024.189191_bb1105) 2019; 38
Guo Rongjao (10.1016/j.bbcan.2024.189191_bb1125) 2010; 25
Liu (10.1016/j.bbcan.2024.189191_bb0255) 2018; 48
Ho (10.1016/j.bbcan.2024.189191_bb1240) 2022; 23
Yang (10.1016/j.bbcan.2024.189191_bb0205) 2017; 10
Chen (10.1016/j.bbcan.2024.189191_bb0435) 2010; 1
Mogler (10.1016/j.bbcan.2024.189191_bb1165) 2015; 14
Luyao (10.1016/j.bbcan.2024.189191_bb0080) 2020; 306
Luo (10.1016/j.bbcan.2024.189191_bb0085) 2013; 46
Lin (10.1016/j.bbcan.2024.189191_bb0190) 2017; 17
Karin (10.1016/j.bbcan.2024.189191_bb0485) 1999; 18
Kim (10.1016/j.bbcan.2024.189191_bb0545) 2014; 5
Han (10.1016/j.bbcan.2024.189191_bb1070) 2017; 38
Jin (10.1016/j.bbcan.2024.189191_bb0855) 2016; 16
Lu (10.1016/j.bbcan.2024.189191_bb0935) 2019; 49
Liu (10.1016/j.bbcan.2024.189191_bb0945) 2018; 8
Fang (10.1016/j.bbcan.2024.189191_bb0665) 2019; 382
Ma (10.1016/j.bbcan.2024.189191_bb0845) 2024; 14
Kikuchi (10.1016/j.bbcan.2024.189191_bb0450) 2022; 125
Yang (10.1016/j.bbcan.2024.189191_bb0355) 2017; 13
Pal (10.1016/j.bbcan.2024.189191_bb1140) 2015; 12
Zhou (10.1016/j.bbcan.2024.189191_bb0215) 2015; 8
Peng (10.1016/j.bbcan.2024.189191_bb1090) 2019; 25
Frisk (10.1016/j.bbcan.2024.189191_bb0090) 2023; 13
Liu (10.1016/j.bbcan.2024.189191_bb1020) 2015; 6
Bapat (10.1016/j.bbcan.2024.189191_bb0125) 2005; 65
Kang (10.1016/j.bbcan.2024.189191_bb0230) 2016; 7
Canfield (10.1016/j.bbcan.2024.189191_bb0705) 2015; 14
Li (10.1016/j.bbcan.2024.189191_bb0465) 2019; 12
Wang (10.1016/j.bbcan.2024.189191_bb0795) 2018; 102
Chen (10.1016/j.bbcan.2024.189191_bb0865) 2014; 4
Seok (10.1016/j.bbcan.2024.189191_bb1265) 2018; 75
Qiu (10.1016/j.bbcan.2024.189191_bb1005) 2018; 8
Zhuang (10.1016/j.bbcan.2024.189191_bb0800) 2023; 83
Li (10.1016/j.bbcan.2024.189191_bb1200) 2021; 41
Dong (10.1016/j.bbcan.2024.189191_bb0965) 2016; 35
Colombo (10.1016/j.bbcan.2024.189191_bb0025) 2017; 27
Schlessinger (10.1016/j.bbcan.2024.189191_bb0275) 2002; 110
Geske (10.1016/j.bbcan.2024.189191_bb1040) 2000; 7
Liu (10.1016/j.bbcan.2024.189191_bb0375) 2021; 12
Jia (10.1016/j.bbcan.2024.189191_bb0765) 2016; 31
Kwon (10.1016/j.bbcan.2024.189191_bb0690) 2024; 57
Liu (10.1016/j.bbcan.2024.189191_bb0645) 2015; 36
Tang (10.1016/j.bbcan.2024.189191_bb1055) 2022; 23
Viatour (10.1016/j.bbcan.2024.189191_bb0495) 2005; 30
Fu (10.1016/j.bbcan.2024.189191_bb0925) 2022; 17
Tan (10.1016/j.bbcan.2024.189191_bb0910) 2022; 22
Stephenson (10.1016/j.bbcan.2024.189191_bb0490) 2023; 299
Zhao (10.1016/j.bbcan.2024.189191_bb0560) 2010; 24
Li (10.1016/j.bbcan.2024.189191_bb0300) 2005; 128
Xiong (10.1016/j.bbcan.2024.189191_bb1210) 2023; 14
Law (10.1016/j.bbcan.2024.189191_bb0295) 2022; 25
Nagaraj (10.1016/j.bbcan.2024.189191_bb0075) 2021; 81
Padthaisong (10.1016/j
References_xml – volume: 12
  start-page: 173
  year: 2019
  end-page: 194
  ident: bb0985
  article-title: A systematic review of miR-29 in cancer
  publication-title: Mol Ther Oncolytics
– volume: 7
  start-page: 393
  year: 2000
  end-page: 401
  ident: bb1040
  article-title: DNA repair is activated in early stages of p53-induced apoptosis
  publication-title: Cell Death Differ.
– year: 2020
  ident: bb0405
  article-title: Integrated analysis of ovarian cancer stem cells-associated lncRNA-miRNA-mRNA network via microarray and Gene Expression Omnibus database
  publication-title: Res Sq Preprint
– volume: 527
  start-page: 153
  year: 2020
  end-page: 161
  ident: bb1215
  article-title: Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 12
  year: 2022
  ident: bb0425
  article-title: Wnt/β-catenin inhibition by CWP232291 as a novel therapeutic strategy in ovarian cancer
  publication-title: Front. Oncol.
– volume: 14
  year: 2021
  ident: bb0460
  article-title: SOS1 promotes epithelial-mesenchymal transition of epithelial ovarian cancer(EOC) cells through AKT independent NF-κB signaling pathway
  publication-title: Transl. Oncol.
– volume: 81
  start-page: 2995
  year: 2021
  end-page: 3007
  ident: bb1095
  article-title: GAS7 deficiency promotes metastasis in MYCN-driven neuroblastoma
  publication-title: Cancer Res.
– volume: 6
  start-page: 34730
  year: 2016
  ident: bb0130
  article-title: Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer
  publication-title: Sci. Rep.
– volume: 8
  start-page: 3080
  year: 2015
  end-page: 3088
  ident: bb0215
  article-title: Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis, Int
  publication-title: J Clin Exp Med
– volume: 48
  start-page: 996
  year: 2023
  end-page: 1008
  ident: bb0330
  article-title: GPR137 inhibits cell proliferation and promotes neuronal differentiation in the neuro2a cells
  publication-title: Neurochem. Res.
– volume: 11
  start-page: 389
  year: 2019
  end-page: 399
  ident: bb0240
  article-title: OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells
  publication-title: Cancer Manag. Res.
– volume: 46
  start-page: 436
  year: 2013
  end-page: 446
  ident: bb0085
  article-title: Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
  publication-title: Cell Prolif.
– volume: 12
  start-page: 3765
  year: 2020
  ident: bb0150
  article-title: Breast cancer stem cells: Biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond
  publication-title: Cancers (Basel)
– volume: 2
  start-page: 900
  year: 2011
  end-page: 909
  ident: bb0370
  article-title: Transcriptional regulation of EGR1 by EGF and the ERK signaling pathway in prostate cancer cells, Genes
  publication-title: Cancer
– volume: 38
  start-page: 3064
  year: 2017
  end-page: 3070
  ident: bb1070
  article-title: Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway
  publication-title: Oncol. Rep.
– volume: 11
  start-page: 23
  year: 2021
  ident: bb0250
  article-title: SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study
  publication-title: Cell Biosci.
– volume: 95
  start-page: 29
  year: 1998
  end-page: 39
  ident: bb0320
  article-title: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
  publication-title: Cell
– volume: 299
  year: 2023
  ident: bb0490
  article-title: The inhibitor of κB kinase β (IKKβ) phosphorylates IκBα twice in a single binding event through a sequential mechanism
  publication-title: J. Biol. Chem.
– volume: 8
  start-page: 12522
  year: 2018
  ident: bb1005
  article-title: Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
  publication-title: Sci. Rep.
– volume: 14
  start-page: 3404
  year: 2023
  end-page: 3415
  ident: bb0110
  article-title: miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression
  publication-title: J. Cancer
– volume: 23
  start-page: 128
  year: 2021
  ident: bb0225
  article-title: Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG
  publication-title: Mol. Med. Rep.
– volume: 83
  start-page: 1611
  year: 2023
  end-page: 1627
  ident: bb0800
  article-title: Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance
  publication-title: Cancer Res.
– volume: 5
  start-page: 1197
  year: 2016
  ident: bb0020
  article-title: Management of relapsed ovarian cancer: a review
  publication-title: Springerplus
– volume: 10
  start-page: 630
  year: 2020
  end-page: 637
  ident: bb1205
  article-title: MicroRNA-155-5p diminishes in vitro ovarian cancer cell viability by targeting HIF1α expression
  publication-title: Adv Pharm Bull
– volume: 79
  start-page: 2314
  year: 2019
  end-page: 2326
  ident: bb0105
  article-title: Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer
  publication-title: Cancer Res.
– volume: 490
  start-page: 20
  year: 2020
  end-page: 30
  ident: bb0905
  article-title: Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway
  publication-title: Cancer Lett.
– volume: 112
  start-page: 4220
  year: 2021
  end-page: 4233
  ident: bb0535
  article-title: Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling
  publication-title: Cancer Sci.
– volume: 14
  start-page: 228
  year: 2023
  ident: bb0310
  article-title: LncRNA HOTAIR down-expression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing TGF-β1 and ZEB1
  publication-title: Discov. Oncol.
– volume: 17
  start-page: 102
  year: 2024
  ident: bb1300
  article-title: Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis
  publication-title: J. Ovarian Res.
– volume: 12
  start-page: 328
  year: 2015
  end-page: 341
  ident: bb1140
  article-title: MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
  publication-title: Cancer Biol. Med.
– volume: 104
  start-page: 9667
  year: 2007
  end-page: 9672
  ident: bb0055
  article-title: Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5 UTR as in the 3 UTR
  publication-title: Proc. Natl. Acad. Sci.
– volume: 16
  year: 2021
  ident: bb0585
  article-title: A link between mitotic defects and mitotic catastrophe: detection and cell fate
  publication-title: Biol. Direct
– volume: 12
  start-page: 269
  year: 2021
  ident: bb0840
  article-title: HMGA2 as a critical regulator in cancer development
  publication-title: Genes (Basel)
– volume: 30
  start-page: 596
  year: 2023
  end-page: 607
  ident: bb0455
  article-title: miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
  publication-title: Cancer Gene Ther.
– volume: 306
  start-page: 461
  year: 2020
  end-page: 472
  ident: bb0080
  article-title: Identification of microRNA expression profiles of CD44+ ovarian cancer stem cells
  publication-title: Arch. Gynecol. Obstet.
– volume: 14
  start-page: 1952
  year: 2022
  ident: bb1180
  article-title: An adenoviral vector as a versatile tool for delivery and expression of miRNAs
  publication-title: Viruses
– volume: 8
  start-page: 5206
  year: 2017
  end-page: 5218
  ident: bb0660
  article-title: MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
  publication-title: Oncotarget
– volume: 38
  year: 2022
  ident: bb1085
  article-title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML
  publication-title: Cell Rep.
– volume: 13
  start-page: 1041
  year: 2017
  end-page: 1047
  ident: bb0355
  article-title: Targeting the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
  publication-title: Oncol. Lett.
– volume: 6
  start-page: 50
  year: 2013
  ident: bb0640
  article-title: MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
  publication-title: J. Ovarian Res.
– volume: 9
  start-page: 47
  year: 2020
  ident: bb0005
  article-title: Magaña-Pérez, Epidemiology of ovarian cancer
  publication-title: Chin. Clin. Oncol.
– volume: 32
  start-page: 2555
  year: 2013
  end-page: 2564
  ident: bb0990
  article-title: Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
  publication-title: Oncogene
– volume: 25
  start-page: 1411
  year: 2019
  end-page: 1422
  ident: bb0835
  article-title: Non-coding RNA Pvt1 promotes cancer stem cell–like traits in nasopharyngeal cancer via inhibiting miR-1207
  publication-title: Pathol. Oncol. Res.
– volume: 7
  start-page: 95
  year: 2022
  ident: bb0510
  article-title: Notch signaling pathway: architecture, disease, and therapeutics
  publication-title: Signal Transduct. Target. Ther.
– volume: 102
  start-page: 147
  year: 2018
  end-page: 152
  ident: bb0795
  article-title: miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer
  publication-title: Biomed. Pharmacother.
– volume: 35
  start-page: 132
  year: 2016
  ident: bb0965
  article-title: MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 1
  start-page: 63
  year: 2013
  end-page: 70
  ident: bb1245
  article-title: miRNA-based therapeutic strategies
  publication-title: Curr. Anesthesiol. Rep.
– volume: 14
  start-page: 314
  year: 2023
  ident: bb1235
  article-title: miRNAs: The road from bench to bedside
  publication-title: Genes (Basel)
– volume: 19
  start-page: 3
  year: 2024
  ident: bb0580
  article-title: GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy
  publication-title: Biol. Direct
– volume: 81
  start-page: 3246
  year: 2021
  end-page: 3261
  ident: bb0420
  article-title: Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation
  publication-title: Mol. Cell
– volume: 131
  start-page: 451
  year: 2013
  end-page: 459
  ident: bb0670
  article-title: The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer
  publication-title: Gynecol. Oncol.
– volume: 15
  start-page: R54
  year: 2013
  ident: bb0520
  article-title: Notch activation stimulates migration of breast cancer cells and promotes tumor growth
  publication-title: Breast Cancer Res.
– volume: 11
  start-page: 383
  year: 2019
  end-page: 397
  ident: bb0040
  article-title: Presence and role of stem cells in ovarian cancer, World
  publication-title: J. Stem Cells
– volume: 25
  year: 2022
  ident: bb0295
  article-title: Premise and peril of Wnt signaling activation through GSK-3b inhibition
  publication-title: IScience
– volume: 22
  start-page: 1490
  year: 2008
  end-page: 1500
  ident: bb0500
  article-title: Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
  publication-title: Genes Dev.
– volume: 39
  start-page: 611
  year: 2013
  end-page: 621
  ident: bb1120
  article-title: Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CTBP2
  publication-title: Immunity
– volume: 45
  start-page: 63
  year: 2021
  ident: bb0335
  article-title: TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis
  publication-title: Oncol. Rep.
– volume: 9
  start-page: 1091
  year: 2015
  end-page: 1105
  ident: bb0570
  article-title: The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
  publication-title: Mol. Oncol.
– volume: 36
  start-page: 4001
  year: 2017
  end-page: 4013
  ident: bb0930
  article-title: Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
  publication-title: Oncogene
– volume: 15
  start-page: 52
  year: 2022
  ident: bb0885
  article-title: miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9
  publication-title: J. Ovarian Res.
– volume: 10
  start-page: 81
  year: 2024
  ident: bb1080
  article-title: CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation
  publication-title: Cell Death Dis.
– volume: 15
  year: 2023
  ident: bb0235
  article-title: Immunohistochemical evaluation of Notch1 in ovarian tumours and its prognostic implications
  publication-title: Cureus
– volume: 11
  start-page: 69
  year: 2018
  ident: bb0140
  article-title: Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
  publication-title: J. Ovarian Res.
– volume: 11
  year: 2016
  ident: bb1145
  article-title: Identification of specific miRNA signature in paired sera and tissue samples of Indian women with triple negative breast cancer
  publication-title: PLoS One
– volume: 4
  start-page: 10
  year: 2021
  ident: bb1155
  article-title: Recent advances in miRNA delivery systems
  publication-title: Methods Protoc
– volume: 22
  start-page: 1277
  year: 2020
  end-page: 1284
  ident: bb0060
  article-title: MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway
  publication-title: Mol. Med. Rep.
– volume: 19
  start-page: 2909
  year: 2020
  end-page: 2915
  ident: bb0790
  article-title: Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells
  publication-title: Oncol. Lett.
– volume: 111
  start-page: 17266
  year: 2014
  end-page: 17271
  ident: bb0120
  article-title: Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 81
  start-page: 2044
  year: 2021
  end-page: 2055
  ident: bb0075
  article-title: The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer
  publication-title: Cancer Res.
– volume: 8
  start-page: 754
  year: 2020
  ident: bb1045
  article-title: miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation
  publication-title: Ann Transl Med
– volume: 13
  year: 2022
  ident: bb0680
  article-title: The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling
  publication-title: Front. Pharmacol.
– volume: 12
  start-page: 5231
  year: 2021
  end-page: 5240
  ident: bb0715
  article-title: miR-3187-3p enhances migration and invasion by targeting PER2 in head and neck squamous cell carcinomas
  publication-title: J. Cancer
– volume: 16
  start-page: 863
  year: 2016
  ident: bb0855
  article-title: Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
  publication-title: BMC Cancer
– volume: 14
  start-page: 606
  year: 2023
  ident: bb0915
  article-title: HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway
  publication-title: Cell Death Dis.
– volume: 18
  start-page: 6867
  year: 1999
  end-page: 6874
  ident: bb0485
  article-title: How NF-kB is activated: the role of the IkB kinase (IKK) complex
  publication-title: Oncogene
– volume: 22
  start-page: 3525
  year: 2021
  end-page: 3531
  ident: bb0210
  article-title: CD133 Act as an essential marker in ovarian carcinogenesis
  publication-title: Asian Pac. J. Cancer Prev.
– volume: 9
  start-page: 1308
  year: 2024
  end-page: 1314
  ident: bb0760
  article-title: MiRNA-3163 limits ovarian cancer stem-like cells via targeting SOX-2 transcription factor
  publication-title: Noncoding RNA Res
– volume: 122
  start-page: 1638
  year: 2020
  end-page: 1648
  ident: bb0430
  article-title: Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
  publication-title: Br. J. Cancer
– volume: 20
  start-page: 897
  year: 2019
  end-page: 911
  ident: bb0620
  article-title: MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2
  publication-title: Cancer Biol. Ther.
– volume: 14
  start-page: 283
  year: 2015
  end-page: 312
  ident: bb1165
  article-title: RNA-based viral vectors RNA-based viral vectors
  publication-title: Expert Rev. Vaccines
– volume: 43
  start-page: 605
  year: 2021
  end-page: 617
  ident: bb0625
  article-title: Evaluating the effect of 3′-utr variants in dicer1 and drosha on their tissue-specific expression by mirna target prediction
  publication-title: Curr. Issues Mol. Biol.
– volume: 14
  start-page: 2796
  year: 2020
  end-page: 2813
  ident: bb0850
  article-title: Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis
  publication-title: Mol. Oncol.
– volume: 605
  start-page: 99
  year: 2017
  end-page: 107
  ident: bb0100
  article-title: MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A
  publication-title: Gene
– volume: 4
  start-page: S1064
  year: 2010
  end-page: S1065
  ident: bb0695
  article-title: MET receptor tyrosine kinase
  publication-title: J. Thorac. Oncol.
– volume: 14
  start-page: 177
  year: 2023
  ident: bb0900
  article-title: PVT1/miR-136/Sox2/UPF1 axis regulates the malignant phenotypes of endometrial cancer stem cells
  publication-title: Cell Death Dis.
– volume: 10
  start-page: 13958
  year: 2020
  ident: bb0805
  article-title: STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
  publication-title: Sci. Rep.
– volume: 12
  start-page: 1
  year: 2020
  end-page: 14
  ident: bb0775
  article-title: CD44S induces miR-629-3p expression in association with cisplatin resistance in head and neck cancer cells
  publication-title: Cancers (Basel)
– volume: 3
  start-page: 16
  year: 2010
  ident: bb1160
  article-title: Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo
  publication-title: Front Neural Circuits
– volume: 31
  start-page: 836
  year: 2016
  end-page: 842
  ident: bb0765
  article-title: Silencing of ABCG2 by microRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells
  publication-title: J. Korean Med. Sci.
– volume: 29
  start-page: 1416
  year: 2015
  end-page: 1431
  ident: bb0550
  article-title: Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling
  publication-title: Genes Dev.
– volume: 6
  start-page: 28882
  year: 2015
  end-page: 28894
  ident: bb0630
  article-title: MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway
  publication-title: Oncotarget
– volume: 41
  start-page: 99
  year: 2021
  end-page: 111
  ident: bb0870
  article-title: HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma
  publication-title: Oncogene
– volume: 27
  start-page: 439
  year: 2022
  end-page: 455
  ident: bb1065
  article-title: Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells
  publication-title: Mol Ther Nucleic Acids
– volume: 18
  start-page: 64
  year: 2020
  ident: bb0175
  article-title: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
  publication-title: J. Transl. Med.
– volume: 10
  start-page: 2951
  year: 2017
  end-page: 2961
  ident: bb0205
  article-title: Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: Evidence from meta-analysis
  publication-title: Onco Targets Ther
– volume: 10
  start-page: 272
  year: 2018
  ident: bb0810
  article-title: miR-1246 targets CCNG2 to enhance cancer stemness and chemoresistance in oral carcinomas
  publication-title: Cancers (Basel)
– volume: 9
  start-page: 139
  year: 2022
  ident: bb1230
  article-title: Beyond safety: mapping the ethical debate on heritable genome editing interventions
  publication-title: Humanit Soc Sci Commun
– volume: 17
  start-page: 8
  year: 2017
  ident: bb0190
  article-title: The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: A meta-analysis
  publication-title: Cancer Cell Int.
– volume: 21
  start-page: 93
  year: 2013
  end-page: 102
  ident: bb0440
  article-title: Balu Senthil Kumar, Kumar Alan Prem, Millward Michael, Arunasalam Dharmarajan, Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
  publication-title: Oncol. Res.
– volume: 82
  start-page: 285
  year: 2002
  end-page: 291
  ident: bb0650
  article-title: Promoter methylation and silencing of PTEN in gastric carcinoma
  publication-title: Lab. Investig.
– volume: 17
  start-page: 3425
  year: 2019
  end-page: 3431
  ident: bb0780
  article-title: MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2
  publication-title: Oncol. Lett.
– volume: 31
  start-page: 725
  year: 2010
  end-page: 732
  ident: bb0745
  article-title: Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway
  publication-title: Acta Pharmacol. Sin.
– volume: 13
  year: 2022
  ident: bb0540
  article-title: The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response
  publication-title: Front. Immunol.
– volume: 396
  start-page: 21
  year: 2017
  end-page: 29
  ident: bb0995
  article-title: Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes
  publication-title: Cancer Lett.
– volume: 4
  start-page: 6413
  year: 2014
  ident: bb0865
  article-title: A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor
  publication-title: Sci. Rep.
– volume: 12
  start-page: 561
  year: 2021
  ident: bb0375
  article-title: Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer
  publication-title: Cell Death Dis.
– volume: 75
  start-page: 797
  year: 2018
  end-page: 814
  ident: bb1265
  article-title: Evaluation and control of miRNA-like off-target repression for RNA interference
  publication-title: Cell. Mol. Life Sci.
– reference: .
– volume: 38
  start-page: 200
  year: 2019
  ident: bb0675
  article-title: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 6
  start-page: 15966
  year: 2015
  end-page: 15983
  ident: bb1020
  article-title: Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
  publication-title: Oncotarget
– volume: 6
  year: 2017
  ident: bb0115
  article-title: miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
  publication-title: Oncogenesis
– volume: 13
  start-page: 4178
  year: 2021
  ident: bb1110
  article-title: Ovarian cancer and cancer stem cells—cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and oncology
  publication-title: Cancers (Basel)
– volume: 14
  start-page: 65
  year: 2023
  ident: bb1210
  article-title: Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
  publication-title: Discov. Oncol.
– volume: 78
  start-page: 1058
  year: 2018
  end-page: 1068
  ident: bb0390
  article-title: Downregulating neuropilin-2 triggers a novel mechanism enabling EGFR-dependent resistance to oncogene-targeted therapies
  publication-title: Cancer Res.
– reference: E. Aparicio-Puerta, P. Hirsch, G.P. Schmartz, F. Kern, T. Fehlmann, A. Keller, MiEAA 2023: Updates, new functional microRNA sets and improved enrichment visualizations, Nucleic Acids Res. 51 (2023) W319–W325. doi:
– volume: 6
  start-page: 9313
  year: 2015
  end-page: 9326
  ident: bb0185
  article-title: Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
  publication-title: Oncotarget
– volume: 19
  start-page: 7
  year: 2020
  ident: bb0575
  article-title: Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
  publication-title: Mol. Cancer
– volume: 42
  start-page: 20
  year: 2023
  ident: bb0875
  article-title: Stroma-derived miR-214 coordinates tumor dissemination
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 11
  start-page: 1057484
  year: 2023
  ident: bb0200
  article-title: Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
  publication-title: Front. Cell Dev. Biol.
– volume: 18
  start-page: 41
  year: 2018
  ident: bb0950
  article-title: LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells
  publication-title: Cancer Cell Int.
– volume: 9
  year: 2021
  ident: bb0755
  article-title: miR-181a-2-3p stimulates gastric cancer progression via targeting MYLK
  publication-title: Front. Bioeng. Biotechnol.
– volume: 13
  start-page: 5613
  year: 2022
  end-page: 5624
  ident: bb0825
  article-title: Knockdown of miR-92a suppresses the stemness of colorectal cancer cells via mediating SOCS3
  publication-title: Bioengineered
– volume: 8
  start-page: 661
  year: 2023
  end-page: 674
  ident: bb1170
  article-title: Methods of miRNA delivery and possibilities of their application in neuro-oncology
  publication-title: Noncoding RNA Res
– volume: 14
  start-page: 4573
  year: 2023
  ident: bb0415
  article-title: Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations
  publication-title: Nat. Commun.
– volume: 18
  start-page: 2256
  year: 2017
  end-page: 2268
  ident: bb0890
  article-title: miR-600 acts as a bimodal switch that regulates breast cancer stem cell fate through WNT signaling
  publication-title: Cell Rep.
– volume: 27
  start-page: 1134
  year: 2017
  end-page: 1140
  ident: bb0025
  article-title: Impact of recurrence of ovarian cancer on quality of life and outlook for the future
  publication-title: Int. J. Gynecol. Cancer
– volume: 125
  year: 2020
  ident: bb0065
  article-title: miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression
  publication-title: Biomed. Pharmacother.
– volume: 35
  start-page: 2027
  year: 2016
  end-page: 2034
  ident: bb0305
  article-title: Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3/-catenin/ZEB1 signaling pathway
  publication-title: Oncol. Rep.
– volume: 29
  start-page: 350
  year: 2008
  end-page: 361
  ident: bb0555
  article-title: Yap1 phosphorylation by c-Abl Is a critical step in selective activation of proapoptotic genes in response to DNA damage
  publication-title: Mol. Cell
– volume: 17
  start-page: 211
  year: 2011
  end-page: 215
  ident: bb0970
  article-title: David Brown, Dean G Tang, The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
  publication-title: Nat. Med.
– volume: 927
  year: 2024
  ident: bb1100
  article-title: Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7
  publication-title: Gene
– volume: 13
  start-page: 871
  year: 2023
  ident: bb0090
  article-title: Circulating microRNAs for early diagnosis of ovarian cancer: A systematic review and meta-analysis
  publication-title: Biomolecules
– volume: 74
  start-page: 463
  year: 1993
  end-page: 474
  ident: bb0600
  article-title: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
  publication-title: Cell
– volume: 19
  start-page: 618
  year: 2019
  ident: bb0265
  article-title: Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
  publication-title: BMC Cancer
– volume: 29
  start-page: 2760
  year: 2022
  end-page: 2767
  ident: bb0095
  article-title: The role of miRNA in ovarian cancer: an overview
  publication-title: Reprod. Sci.
– volume: 12
  start-page: 120
  year: 2019
  ident: bb0045
  article-title: Ovarian cancer stem cells and targeted therapy
  publication-title: J. Ovarian Res.
– volume: 3
  start-page: 1302
  year: 2013
  end-page: 1315
  ident: bb1190
  article-title: Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
  publication-title: Cancer Discov.
– volume: 7
  start-page: 68229
  year: 2016
  end-page: 68241
  ident: bb0230
  article-title: Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain
  publication-title: Oncotarget
– volume: 133
  start-page: 867
  year: 2013
  end-page: 878
  ident: bb0260
  article-title: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
  publication-title: Int. J. Cancer
– volume: 180
  start-page: 1159
  year: 2012
  end-page: 1169
  ident: bb0170
  article-title: ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome
  publication-title: Am. J. Pathol.
– volume: 22
  start-page: 751
  year: 2022
  ident: bb0380
  article-title: Targeting the transcriptional activity of STAT3 by a novel fusion protein
  publication-title: BMC Cancer
– volume: 8
  year: 2013
  ident: bb0365
  article-title: Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells
  publication-title: PLoS One
– volume: 12
  start-page: 101
  year: 2019
  end-page: 112
  ident: bb0465
  article-title: NF-κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-α and TGF-β, Int
  publication-title: J Clin Exp Pathol
– volume: 36
  start-page: 5927
  year: 2017
  end-page: 5938
  ident: bb0980
  article-title: Wong, β-catenin downregulates Dicer to promote ovarian cancer metastasis
  publication-title: Oncogene
– volume: 110
  start-page: 669
  year: 2002
  end-page: 672
  ident: bb0275
  article-title: Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
  publication-title: Cell
– volume: 30
  start-page: 43
  year: 2005
  end-page: 52
  ident: bb0495
  article-title: Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation
  publication-title: Trends Biochem. Sci.
– volume: 22
  start-page: 905
  year: 2022
  ident: bb0910
  article-title: Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
  publication-title: BMC Cancer
– volume: 6
  start-page: 18
  year: 2013
  ident: bb1115
  article-title: MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
  publication-title: J. Ovarian Res.
– volume: 501
  start-page: 486
  year: 2018
  end-page: 493
  ident: bb1030
  article-title: MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 5
  start-page: 5370
  year: 2014
  ident: bb0545
  article-title: The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis
  publication-title: Nat. Commun.
– volume: 40
  start-page: 5131
  year: 2021
  end-page: 5141
  ident: bb0315
  article-title: ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers
  publication-title: Oncogene
– volume: 24
  start-page: 72
  year: 2010
  end-page: 85
  ident: bb0560
  article-title: A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP
  publication-title: Genes Dev.
– volume: 28
  start-page: 53
  year: 2023
  ident: bb0940
  article-title: EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells
  publication-title: Cell. Mol. Biol. Lett.
– volume: 13
  start-page: 16
  year: 2020
  ident: bb1025
  article-title: Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids
  publication-title: J. Ovarian Res.
– volume: 17
  start-page: 58
  year: 2018
  ident: bb0270
  article-title: Mechanisms of receptor tyrosine kinase activation in cancer
  publication-title: Mol. Cancer
– volume: 54
  start-page: 1637
  year: 2022
  end-page: 1647
  ident: bb0325
  article-title: Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs
  publication-title: Acta Biochim. Biophys. Sin. Shanghai
– volume: 14
  start-page: 154
  year: 2021
  ident: bb0710
  article-title: RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis
  publication-title: J. Ovarian Res.
– volume: 6
  start-page: 37652
  year: 2016
  ident: bb0475
  article-title: TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
  publication-title: Sci. Rep.
– volume: 10
  start-page: 11
  year: 2017
  ident: bb0135
  article-title: Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
  publication-title: J. Ovarian Res.
– volume: 6
  start-page: 13
  year: 2017
  ident: bb0350
  article-title: Activation of the EGF receptor by ligand binding and oncogenic mutations: The rotation model
  publication-title: Cells
– volume: 486
  start-page: 1129
  year: 2017
  end-page: 1136
  ident: bb0815
  article-title: Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 14
  start-page: 648
  year: 2015
  end-page: 655
  ident: bb0705
  article-title: Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
  publication-title: Cell Cycle
– volume: 250
  start-page: 159
  year: 2020
  end-page: 169
  ident: bb0165
  article-title: ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors
  publication-title: J. Pathol.
– volume: 11
  start-page: 36
  year: 2018
  ident: bb0220
  article-title: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: Studies based on the CRISPR/Cas9 system
  publication-title: J. Ovarian Res.
– volume: 128
  start-page: 1907
  year: 2005
  end-page: 1918
  ident: bb0300
  article-title: Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3β
  publication-title: Gastroenterology
– volume: 57
  year: 2024
  ident: bb0690
  article-title: MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs
  publication-title: Cell Prolif.
– volume: 1
  start-page: 639
  year: 2002
  end-page: 649
  ident: bb0615
  article-title: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
  publication-title: Mol. Cancer Ther.
– volume: 23
  start-page: 186
  year: 2013
  end-page: 199
  ident: bb1195
  article-title: Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
  publication-title: Cancer Cell
– volume: 125
  start-page: 55
  year: 2022
  end-page: 65
  ident: bb0450
  article-title: Dickkopf signaling, beyond Wnt-mediated biology
  publication-title: Semin. Cell Dev. Biol.
– volume: 11
  year: 2021
  ident: bb1015
  article-title: miR-186 Inhibits liver cancer stem cells expansion via targeting PTPN11
  publication-title: Front. Oncol.
– volume: 5
  start-page: 18
  year: 2012
  ident: bb0070
  article-title: MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
  publication-title: BMC Med. Genet.
– volume: 14
  start-page: 85
  year: 2014
  ident: bb0960
  article-title: MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
  publication-title: BMC Cancer
– volume: 2021
  start-page: 8842554
  year: 2021
  ident: bb0565
  article-title: Evaluation of Hippo pathway and CD133 in radiation resistance in small-cell lung cancer
  publication-title: J. Oncol.
– volume: 13
  start-page: 8938
  year: 2021
  end-page: 8951
  ident: bb0400
  article-title: NRP2, a potential biomarker for oral squamous cell carcinoma
  publication-title: Am. J. Transl. Res.
– volume: 8
  start-page: 3538
  year: 2017
  end-page: 3547
  ident: bb0340
  article-title: Clinical impact of microRNAs associated with cancer stem cells as a prognostic factor in ovarian carcinoma
  publication-title: J. Cancer
– volume: 29
  start-page: 803
  year: 2022
  end-page: 822
  ident: bb0605
  article-title: MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
  publication-title: Mol Ther Nucleic Acids
– volume: 20
  start-page: 5168
  year: 2019
  ident: bb0590
  article-title: Emerging roles of DDB2 in cancer
  publication-title: Int. J. Mol. Sci.
– volume: 23
  start-page: 10064
  year: 2022
  ident: bb1060
  article-title: The distinct roles of LKB1 and AMPK in p53-dependent apoptosis induced by cisplatin
  publication-title: Int. J. Mol. Sci.
– volume: 8
  start-page: 57
  year: 2017
  end-page: 64
  ident: bb1175
  article-title: Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
  publication-title: J. Cancer
– volume: 382
  year: 2019
  ident: bb0665
  article-title: Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c
  publication-title: Exp. Cell Res.
– volume: 41
  start-page: 4755
  year: 2012
  end-page: 4767
  ident: bb1185
  article-title: Branched and linear poly(ethylene imine)-based conjugates: Synthetic modification, characterization, and application
  publication-title: Chem. Soc. Rev.
– volume: 14
  start-page: 28
  year: 2023
  ident: bb0030
  article-title: Targeting ovarian cancer stem cells: a new way out
  publication-title: Stem Cell Res Ther
– volume: 38
  year: 2018
  ident: bb1130
  article-title: Ultrasound microbubbles mediated miR-let-7b delivery into CD133+ ovarian cancer stem cells
  publication-title: Biosci. Rep.
– volume: 48
  start-page: 1505
  year: 2018
  end-page: 1518
  ident: bb0255
  article-title: HDAC1 silencing in ovarian cancer enhances the chemotherapy response
  publication-title: Cell. Physiol. Biochem.
– volume: 10
  year: 2021
  ident: bb0280
  article-title: Akt phosphorylates insulin receptor substrate to limit pi3k-mediated pip3 synthesis
  publication-title: Elife
– volume: 526
  start-page: 158
  year: 2020
  end-page: 164
  ident: bb0345
  article-title: Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated STAT5 pathway
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 8
  start-page: 8704
  year: 2018
  ident: bb0470
  article-title: Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
  publication-title: Sci. Rep.
– volume: 8
  start-page: 5801
  year: 2018
  end-page: 5813
  ident: bb0945
  article-title: miR-200c/141 regulates breast cancer stem cell heterogeneity via targeting HIPK1/β-catenin axis
  publication-title: Theranostics
– volume: 23
  start-page: 8520
  year: 2004
  end-page: 8526
  ident: bb0445
  article-title: DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
  publication-title: Oncogene
– volume: 7
  start-page: 62019
  year: 2016
  end-page: 62033
  ident: bb1135
  article-title: Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition
  publication-title: Oncotarget
– volume: 2
  start-page: 89
  year: 2023
  end-page: 99
  ident: bb1035
  article-title: Evaluation of miRNA-derived extracellular vesicles as biomarkers in ovarian cancer stem cells
  publication-title: Cancer Screening and Prevention
– volume: 12
  start-page: 15437
  year: 2022
  ident: bb1000
  article-title: ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model
  publication-title: Sci. Rep.
– volume: 108
  start-page: 719
  year: 2017
  end-page: 731
  ident: bb0245
  article-title: SOX2 is required to maintain cancer stem cells in ovarian cancer
  publication-title: Cancer Sci.
– volume: 22
  start-page: 10216
  year: 2021
  ident: bb0730
  article-title: MiR-125a-3p and miR-320b differentially expressed in patients with chronic myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation and imatinib mesylate
  publication-title: Int. J. Mol. Sci.
– volume: 7
  start-page: 63342
  year: 2016
  end-page: 63351
  ident: bb0505
  article-title: Rab27A mediated by NF-κB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion
  publication-title: Oncotarget
– volume: 34
  start-page: 44
  year: 2022
  ident: bb0180
  article-title: CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
  publication-title: J. Egypt. Natl. Canc. Inst.
– volume: 1
  start-page: 210
  year: 2010
  end-page: 218
  ident: bb0435
  article-title: Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
  publication-title: Oncotarget
– volume: 15
  start-page: 97
  year: 2022
  ident: bb0770
  article-title: Differentially expression and function of circular RNAs in ovarian cancer stem cells
  publication-title: J. Ovarian Res.
– volume: 36
  start-page: 1881
  year: 2015
  end-page: 1893
  ident: bb0645
  article-title: MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway
  publication-title: Tumour Biol.
– volume: 13
  start-page: 18653
  year: 2023
  ident: bb0735
  article-title: The amphiregulin/EGFR axis has limited contribution in controlling autoimmune diabetes
  publication-title: Sci. Rep.
– volume: 35
  start-page: 12189
  year: 2014
  end-page: 12200
  ident: bb0750
  article-title: MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data
  publication-title: Tumour Biol.
– volume: 15
  start-page: 987
  year: 2020
  end-page: 992
  ident: bb1270
  article-title: Challenges identifying efficacious miRNA therapeutics for cancer
  publication-title: Expert Opin. Drug Discov.
– volume: 282
  start-page: 19426
  year: 2007
  end-page: 19441
  ident: bb0360
  article-title: Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration
  publication-title: J. Biol. Chem.
– volume: 7
  start-page: 190
  year: 2019
  ident: bb0145
  article-title: Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
  publication-title: J. Immunother. Cancer
– volume: 110
  start-page: 2063
  year: 2014
  end-page: 2071
  ident: bb0155
  article-title: Lack of correlation of stem cell markers in breast cancer stem cells
  publication-title: Br. J. Cancer
– volume: 27
  year: 2023
  ident: bb0720
  article-title: Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway
  publication-title: Transl. Oncol.
– volume: 23
  start-page: 7167
  year: 2022
  ident: bb1240
  article-title: MicroRNA-based diagnosis and therapy
  publication-title: Int. J. Mol. Sci.
– volume: 21
  start-page: 377
  year: 2021
  ident: bb1075
  article-title: Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
  publication-title: BMC Gastroenterol.
– volume: 24
  start-page: 10337
  year: 2023
  ident: bb0480
  article-title: The recent research progress of NF-κB signaling on the proliferation, migration, invasion, immune escape and drug resistance of glioblastoma
  publication-title: Int. J. Mol. Sci.
– volume: 29
  start-page: 76
  year: 2022
  ident: bb0290
  article-title: Akt: a key transducer in cancer
  publication-title: J. Biomed. Sci.
– volume: 29
  start-page: 3545
  year: 2010
  end-page: 3553
  ident: bb0860
  article-title: TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214
  publication-title: Oncogene
– volume: 14
  start-page: 94
  year: 2019
  end-page: 106
  ident: bb0410
  article-title: Silencing LGR6 attenuates stemness and chemoresistance via inhibiting Wnt/β-Catenin signaling in ovarian cancer
  publication-title: Mol Ther Oncolytics
– volume: 116
  start-page: 66
  year: 2017
  end-page: 76
  ident: bb1225
  article-title: MicroRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
  publication-title: Br. J. Cancer
– volume: 25
  start-page: 141
  year: 2010
  end-page: 146
  ident: bb1125
  article-title: Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3
  publication-title: Oncol. Rep.
– volume: 5
  start-page: 304
  year: 2022
  end-page: 316
  ident: bb0015
  article-title: Mechanisms of chemotherapy resistance in ovarian cancer
  publication-title: Cancer Drug Resistance
– volume: 65
  start-page: 3025
  year: 2005
  end-page: 3029
  ident: bb0125
  article-title: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
  publication-title: Cancer Res.
– volume: 6
  start-page: 402
  year: 2021
  ident: bb0830
  article-title: The JAK/STAT signaling pathway: from bench to clinic
  publication-title: Signal Transduct. Target. Ther.
– volume: 23
  year: 2022
  ident: bb1055
  article-title: Tumor suppressor miRNA-503 inhibits cell invasion in head and neck cancer through the Wnt signaling pathway via the WNT3A/MMP molecular axis
  publication-title: Int. J. Mol. Sci.
– volume: 24
  start-page: 279
  year: 2019
  end-page: 289
  ident: bb0655
  article-title: MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN
  publication-title: Cancer Biomark.
– volume: 6
  start-page: 1967
  year: 2014
  end-page: 1984
  ident: bb1250
  article-title: miRNA-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents, Future
  publication-title: Med. Chem.
– volume: 37
  start-page: 3189
  year: 2017
  end-page: 3200
  ident: bb0195
  article-title: CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
  publication-title: Oncol. Rep.
– volume: 122
  start-page: 149
  year: 2011
  end-page: 154
  ident: bb0955
  article-title: MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
  publication-title: Gynecol. Oncol.
– volume: 20
  start-page: 15
  year: 2022
  ident: bb0160
  article-title: Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
  publication-title: World J. Surg. Oncol.
– volume: 77
  start-page: 1955
  year: 2017
  end-page: 1967
  ident: bb0820
  article-title: The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer
  publication-title: Cancer Res.
– volume: 47
  start-page: 202
  year: 2011
  end-page: 210
  ident: bb1010
  article-title: MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation
  publication-title: Oral Oncol.
– volume: 12
  start-page: 122
  year: 2019
  end-page: 134
  ident: bb0685
  article-title: A miRNA-mediated approach to dissect the complexity of tumor-initiating cell function and identify miRNA-targeting drugs
  publication-title: Stem Cell Rep.
– volume: 47
  start-page: 2147
  year: 2018
  end-page: 2158
  ident: bb0975
  article-title: MiR-137 suppresses triple-negative breast cancer stemness and tumorigenesis by perturbing BCL11A-DNMT1 interaction
  publication-title: Cell. Physiol. Biochem.
– volume: 5
  start-page: 207
  year: 2000
  end-page: 216
  ident: bb0515
  article-title: A novel proteolytic cleavage involved in Notch signaling: The role of the disintegrin-metalloprotease TACE
  publication-title: Mol. Cell
– volume: 49
  start-page: 361
  year: 2019
  end-page: 374
  ident: bb0935
  article-title: Epithelial-mesenchymal plasticity in cancer progression and metastasis
  publication-title: Dev. Cell
– volume: 81
  start-page: 10
  year: 2024
  ident: bb0700
  article-title: miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34+ cells partially via SERPINE1
  publication-title: Cell. Mol. Life Sci.
– volume: 386
  start-page: 168
  year: 2017
  end-page: 178
  ident: bb0635
  article-title: MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3
  publication-title: Cancer Lett.
– volume: 14
  start-page: 5093
  year: 2022
  ident: bb0395
  article-title: CEMIP, a promising biomarker that promotes the progression and metastasis of colorectal and other types of cancer
  publication-title: Cancers (Basel)
– volume: 14
  start-page: 1320887
  year: 2024
  ident: bb0845
  article-title: HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition
  publication-title: Front. Oncol.
– volume: 1
  start-page: 24
  year: 2019
  ident: bb1150
  article-title: Recent progress in microRNA-based delivery systems for the treatment of human disease
  publication-title: ExRNA
– volume: 112
  year: 2022
  ident: bb0595
  article-title: DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma
  publication-title: DNA Repair (Amst)
– volume: 77
  start-page: 1613
  year: 2021
  end-page: 1626
  ident: bb0530
  article-title: MicroRNA-874-3p/ADAM (A disintegrin and metalloprotease) 19 mediates macrophage activation and renal fibrosis after acute kidney injury
  publication-title: Hypertension
– volume: 12
  start-page: 15650
  year: 2022
  ident: bb0525
  article-title: TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells
  publication-title: Sci. Rep.
– volume: 15
  start-page: 3781
  year: 2024
  end-page: 3793
  ident: bb0785
  article-title: Linc00662 sponges miR-15b-5p to promote hypopharyngeal squamous cell carcinoma progression by facilitating cancer stem cell-like phenotypes
  publication-title: J. Cancer
– volume: 15
  start-page: 248
  year: 2019
  end-page: 260
  ident: bb0725
  article-title: miR-424-5p promotes anoikis resistance and lung metastasis by inactivating Hippo signaling in thyroid cancer
  publication-title: Mol Ther Oncolytics
– volume: 14
  start-page: 513
  year: 2023
  ident: bb0895
  article-title: Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
  publication-title: Cell Death Dis.
– volume: 7
  start-page: 076
  year: 2021
  ident: bb0035
  article-title: Cancer stem cell assay for the treatment of platinum-resistant recurrent ovarian cancer
  publication-title: Journal of Stem Cells Research, Development & Therapy
– volume: 40
  start-page: 1574
  year: 2018
  end-page: 1582
  ident: bb0610
  article-title: S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53
  publication-title: Oncol. Rep.
– volume: 14
  year: 2019
  ident: bb1220
  article-title: Human CAP cells represent a novel source for functional, miRNA-loaded exosome production
  publication-title: PLoS One
– volume: 25
  start-page: 217
  year: 2019
  end-page: 223
  ident: bb1090
  article-title: Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer
  publication-title: Innate Immun.
– volume: 117
  start-page: 1665
  year: 2017
  end-page: 1675
  ident: bb1050
  article-title: Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis
  publication-title: Br. J. Cancer
– volume: 44
  start-page: 2437
  year: 2022
  end-page: 2451
  ident: bb0740
  article-title: Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells
  publication-title: Head Neck
– volume: 277
  start-page: 9684
  year: 2002
  end-page: 9689
  ident: bb0285
  article-title: Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation
  publication-title: J. Biol. Chem.
– volume: 41
  start-page: 736
  year: 2021
  end-page: 746
  ident: bb1200
  article-title: Development and functional validation of a nano-delivery system of miR-16/polypeptide targeting ovarian cancer cells
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– volume: 588
  start-page: 981
  year: 2014
  end-page: 989
  ident: bb0385
  article-title: PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis
  publication-title: FEBS Lett.
– volume: 17
  start-page: 102
  year: 2022
  end-page: 106
  ident: bb0925
  article-title: Regulation of miR-30b in cancer development, apoptosis, and drug resistance, Open
  publication-title: Life Sci.
– volume: 11
  start-page: 287
  year: 2019
  end-page: 299
  ident: bb0010
  article-title: Ovarian cancer in the world: Epidemiology and risk factors
  publication-title: Int. J. Women's Health
– volume: 478
  start-page: 305
  year: 2023
  end-page: 315
  ident: bb0880
  article-title: SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines
  publication-title: Mol. Cell. Biochem.
– volume: 38
  start-page: 2923
  year: 2019
  end-page: 2936
  ident: bb1105
  article-title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma
  publication-title: Oncogene
– volume: 54
  start-page: 1637
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0325
  article-title: Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs
  publication-title: Acta Biochim. Biophys. Sin. Shanghai
  doi: 10.3724/abbs.2022159
– volume: 14
  start-page: 94
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0410
  article-title: Silencing LGR6 attenuates stemness and chemoresistance via inhibiting Wnt/β-Catenin signaling in ovarian cancer
  publication-title: Mol Ther Oncolytics
  doi: 10.1016/j.omto.2019.04.002
– volume: 29
  start-page: 350
  year: 2008
  ident: 10.1016/j.bbcan.2024.189191_bb0555
  article-title: Yap1 phosphorylation by c-Abl Is a critical step in selective activation of proapoptotic genes in response to DNA damage
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2007.12.022
– volume: 7
  start-page: 076
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0035
  article-title: Cancer stem cell assay for the treatment of platinum-resistant recurrent ovarian cancer
  publication-title: Journal of Stem Cells Research, Development & Therapy
– volume: 18
  start-page: 6867
  year: 1999
  ident: 10.1016/j.bbcan.2024.189191_bb0485
  article-title: How NF-kB is activated: the role of the IkB kinase (IKK) complex
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203219
– volume: 6
  start-page: 15966
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb1020
  article-title: Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3862
– volume: 7
  start-page: 393
  year: 2000
  ident: 10.1016/j.bbcan.2024.189191_bb1040
  article-title: DNA repair is activated in early stages of p53-induced apoptosis
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4400663
– volume: 7
  start-page: 190
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0145
  article-title: Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-019-0666-1
– volume: 13
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0540
  article-title: The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response
  publication-title: Front. Immunol.
– volume: 133
  start-page: 867
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0260
  article-title: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28086
– volume: 22
  start-page: 905
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0910
  article-title: Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
  publication-title: BMC Cancer
  doi: 10.1186/s12885-022-09999-y
– volume: 78
  start-page: 1058
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0390
  article-title: Downregulating neuropilin-2 triggers a novel mechanism enabling EGFR-dependent resistance to oncogene-targeted therapies
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-17-2020
– volume: 83
  start-page: 1611
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0800
  article-title: Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-22-2213
– volume: 12
  start-page: 120
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0045
  article-title: Ovarian cancer stem cells and targeted therapy
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-019-0588-z
– volume: 15
  start-page: 97
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0770
  article-title: Differentially expression and function of circular RNAs in ovarian cancer stem cells
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-022-01014-z
– volume: 12
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0425
  article-title: Wnt/β-catenin inhibition by CWP232291 as a novel therapeutic strategy in ovarian cancer
  publication-title: Front. Oncol.
– volume: 23
  start-page: 8520
  year: 2004
  ident: 10.1016/j.bbcan.2024.189191_bb0445
  article-title: DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207892
– volume: 8
  start-page: 57
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb1175
  article-title: Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
  publication-title: J. Cancer
  doi: 10.7150/jca.16723
– volume: 30
  start-page: 596
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0455
  article-title: miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
  publication-title: Cancer Gene Ther.
  doi: 10.1038/s41417-022-00574-y
– volume: 526
  start-page: 158
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0345
  article-title: Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated STAT5 pathway
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2020.03.046
– volume: 12
  start-page: 15650
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0525
  article-title: TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-18662-2
– volume: 27
  start-page: 439
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1065
  article-title: Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2021.12.021
– volume: 29
  start-page: 1416
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0550
  article-title: Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling
  publication-title: Genes Dev.
  doi: 10.1101/gad.264929.115
– volume: 21
  start-page: 377
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1075
  article-title: Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
  publication-title: BMC Gastroenterol.
  doi: 10.1186/s12876-021-01962-8
– volume: 22
  start-page: 1490
  year: 2008
  ident: 10.1016/j.bbcan.2024.189191_bb0500
  article-title: Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
  publication-title: Genes Dev.
  doi: 10.1101/gad.1662308
– volume: 46
  start-page: 436
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0085
  article-title: Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12038
– volume: 41
  start-page: 4755
  year: 2012
  ident: 10.1016/j.bbcan.2024.189191_bb1185
  article-title: Branched and linear poly(ethylene imine)-based conjugates: Synthetic modification, characterization, and application
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/c2cs35146c
– volume: 6
  start-page: 50
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0640
  article-title: MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
  publication-title: J. Ovarian Res.
  doi: 10.1186/1757-2215-6-50
– volume: 588
  start-page: 981
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0385
  article-title: PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2014.01.058
– volume: 25
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0295
  article-title: Premise and peril of Wnt signaling activation through GSK-3b inhibition
  publication-title: IScience
  doi: 10.1016/j.isci.2022.104159
– volume: 11
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1015
  article-title: miR-186 Inhibits liver cancer stem cells expansion via targeting PTPN11
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.632976
– volume: 11
  start-page: 1057484
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0200
  article-title: Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2023.1057484
– volume: 3
  start-page: 16
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb1160
  article-title: Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo
  publication-title: Front Neural Circuits
– volume: 112
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0595
  article-title: DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma
  publication-title: DNA Repair (Amst)
  doi: 10.1016/j.dnarep.2022.103302
– volume: 8
  start-page: 754
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb1045
  article-title: miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation
  publication-title: Ann Transl Med
  doi: 10.21037/atm-20-3749
– volume: 34
  start-page: 44
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0180
  article-title: CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
  publication-title: J. Egypt. Natl. Canc. Inst.
  doi: 10.1186/s43046-022-00143-2
– volume: 5
  start-page: 207
  year: 2000
  ident: 10.1016/j.bbcan.2024.189191_bb0515
  article-title: A novel proteolytic cleavage involved in Notch signaling: The role of the disintegrin-metalloprotease TACE
  publication-title: Mol. Cell
  doi: 10.1016/S1097-2765(00)80417-7
– volume: 12
  start-page: 122
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0685
  article-title: A miRNA-mediated approach to dissect the complexity of tumor-initiating cell function and identify miRNA-targeting drugs
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2018.12.002
– volume: 8
  start-page: 661
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb1170
  article-title: Methods of miRNA delivery and possibilities of their application in neuro-oncology
  publication-title: Noncoding RNA Res
  doi: 10.1016/j.ncrna.2023.10.002
– volume: 81
  start-page: 2995
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1095
  article-title: GAS7 deficiency promotes metastasis in MYCN-driven neuroblastoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-20-1890
– volume: 11
  start-page: 389
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0240
  article-title: OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S180418
– volume: 18
  start-page: 41
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0950
  article-title: LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-018-0540-0
– volume: 6
  start-page: 28882
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0630
  article-title: MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4921
– volume: 13
  start-page: 1041
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0355
  article-title: Targeting the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2017.5557
– volume: 48
  start-page: 1505
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0255
  article-title: HDAC1 silencing in ovarian cancer enhances the chemotherapy response
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000492260
– volume: 14
  start-page: 1952
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1180
  article-title: An adenoviral vector as a versatile tool for delivery and expression of miRNAs
  publication-title: Viruses
  doi: 10.3390/v14091952
– volume: 75
  start-page: 797
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb1265
  article-title: Evaluation and control of miRNA-like off-target repression for RNA interference
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-017-2656-0
– volume: 35
  start-page: 12189
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0750
  article-title: MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2527-3
– volume: 110
  start-page: 2063
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0155
  article-title: Lack of correlation of stem cell markers in breast cancer stem cells
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2014.105
– volume: 8
  start-page: 8704
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0470
  article-title: Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-27021-z
– volume: 12
  start-page: 3765
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0150
  article-title: Breast cancer stem cells: Biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12123765
– volume: 8
  start-page: 5801
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0945
  article-title: miR-200c/141 regulates breast cancer stem cell heterogeneity via targeting HIPK1/β-catenin axis
  publication-title: Theranostics
  doi: 10.7150/thno.29380
– volume: 22
  start-page: 10216
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0730
  article-title: MiR-125a-3p and miR-320b differentially expressed in patients with chronic myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation and imatinib mesylate
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms221910216
– volume: 29
  start-page: 803
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0605
  article-title: MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2022.08.028
– volume: 490
  start-page: 20
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0905
  article-title: Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2020.06.009
– volume: 527
  start-page: 153
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb1215
  article-title: Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2020.04.076
– volume: 131
  start-page: 451
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0670
  article-title: The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2013.07.112
– volume: 396
  start-page: 21
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0995
  article-title: Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.03.010
– volume: 81
  start-page: 2044
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0075
  article-title: The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-20-2041
– volume: 5
  start-page: 18
  year: 2012
  ident: 10.1016/j.bbcan.2024.189191_bb0070
  article-title: MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
  publication-title: BMC Med. Genet.
– volume: 81
  start-page: 3246
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0420
  article-title: Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2021.07.013
– volume: 122
  start-page: 149
  year: 2011
  ident: 10.1016/j.bbcan.2024.189191_bb0955
  article-title: MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2011.03.026
– volume: 386
  start-page: 168
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0635
  article-title: MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2016.11.017
– volume: 38
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb1130
  article-title: Ultrasound microbubbles mediated miR-let-7b delivery into CD133+ ovarian cancer stem cells
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20180922
– volume: 125
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0065
  article-title: miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2020.109865
– volume: 10
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0280
  article-title: Akt phosphorylates insulin receptor substrate to limit pi3k-mediated pip3 synthesis
  publication-title: Elife
  doi: 10.7554/eLife.66942
– volume: 13
  start-page: 18653
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0735
  article-title: The amphiregulin/EGFR axis has limited contribution in controlling autoimmune diabetes
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-023-45738-4
– volume: 25
  start-page: 141
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb1125
  article-title: Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3
  publication-title: Oncol. Rep.
– volume: 82
  start-page: 285
  year: 2002
  ident: 10.1016/j.bbcan.2024.189191_bb0650
  article-title: Promoter methylation and silencing of PTEN in gastric carcinoma
  publication-title: Lab. Investig.
  doi: 10.1038/labinvest.3780422
– volume: 31
  start-page: 725
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb0745
  article-title: Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2010.56
– volume: 14
  start-page: 513
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0895
  article-title: Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-06028-z
– volume: 4
  start-page: 6413
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0865
  article-title: A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor
  publication-title: Sci. Rep.
  doi: 10.1038/srep06413
– volume: 16
  start-page: 863
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0855
  article-title: Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
  publication-title: BMC Cancer
  doi: 10.1186/s12885-016-2904-y
– ident: 10.1016/j.bbcan.2024.189191_bb0050
  doi: 10.1093/nar/gkad392
– volume: 19
  start-page: 7
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0575
  article-title: Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-020-1130-z
– volume: 36
  start-page: 5927
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0980
  article-title: Wong, β-catenin downregulates Dicer to promote ovarian cancer metastasis
  publication-title: Oncogene
  doi: 10.1038/onc.2017.185
– volume: 38
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1085
  article-title: Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.110481
– volume: 605
  start-page: 99
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0100
  article-title: MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A
  publication-title: Gene
  doi: 10.1016/j.gene.2016.12.030
– volume: 14
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0460
  article-title: SOS1 promotes epithelial-mesenchymal transition of epithelial ovarian cancer(EOC) cells through AKT independent NF-κB signaling pathway
  publication-title: Transl. Oncol.
  doi: 10.1016/j.tranon.2021.101160
– volume: 20
  start-page: 15
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0160
  article-title: Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
  publication-title: World J. Surg. Oncol.
  doi: 10.1186/s12957-021-02469-y
– volume: 16
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0585
  article-title: A link between mitotic defects and mitotic catastrophe: detection and cell fate
  publication-title: Biol. Direct
  doi: 10.1186/s13062-021-00313-7
– volume: 9
  start-page: 47
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0005
  article-title: Magaña-Pérez, Epidemiology of ovarian cancer
  publication-title: Chin. Clin. Oncol.
  doi: 10.21037/cco-20-34
– volume: 20
  start-page: 5168
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0590
  article-title: Emerging roles of DDB2 in cancer
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20205168
– volume: 6
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0115
  article-title: miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
  publication-title: Oncogenesis
  doi: 10.1038/oncsis.2017.25
– volume: 13
  start-page: 5613
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0825
  article-title: Knockdown of miR-92a suppresses the stemness of colorectal cancer cells via mediating SOCS3
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.2022267
– volume: 38
  start-page: 2923
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb1105
  article-title: miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0601-9
– volume: 31
  start-page: 836
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0765
  article-title: Silencing of ABCG2 by microRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells
  publication-title: J. Korean Med. Sci.
  doi: 10.3346/jkms.2016.31.6.836
– volume: 104
  start-page: 9667
  year: 2007
  ident: 10.1016/j.bbcan.2024.189191_bb0055
  article-title: Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5 UTR as in the 3 UTR
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0703820104
– volume: 13
  start-page: 8938
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0400
  article-title: NRP2, a potential biomarker for oral squamous cell carcinoma
  publication-title: Am. J. Transl. Res.
– volume: 29
  start-page: 76
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0290
  article-title: Akt: a key transducer in cancer
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-022-00860-9
– volume: 29
  start-page: 2760
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0095
  article-title: The role of miRNA in ovarian cancer: an overview
  publication-title: Reprod. Sci.
  doi: 10.1007/s43032-021-00717-w
– volume: 128
  start-page: 1907
  year: 2005
  ident: 10.1016/j.bbcan.2024.189191_bb0300
  article-title: Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3β
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.02.067
– volume: 12
  start-page: 173
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0985
  article-title: A systematic review of miR-29 in cancer
  publication-title: Mol Ther Oncolytics
  doi: 10.1016/j.omto.2018.12.011
– volume: 23
  start-page: 186
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb1195
  article-title: Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.12.020
– volume: 12
  start-page: 5231
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0715
  article-title: miR-3187-3p enhances migration and invasion by targeting PER2 in head and neck squamous cell carcinomas
  publication-title: J. Cancer
  doi: 10.7150/jca.58593
– volume: 122
  start-page: 1638
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0430
  article-title: Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-020-0825-7
– volume: 478
  start-page: 305
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0880
  article-title: SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-022-04507-z
– volume: 17
  start-page: 58
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0270
  article-title: Mechanisms of receptor tyrosine kinase activation in cancer
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0782-4
– volume: 6
  start-page: 1967
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb1250
  article-title: miRNA-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents, Future
  publication-title: Med. Chem.
– volume: 22
  start-page: 1277
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0060
  article-title: MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2020.11236
– volume: 6
  start-page: 37652
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0475
  article-title: TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
  publication-title: Sci. Rep.
  doi: 10.1038/srep37652
– volume: 42
  start-page: 20
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0875
  article-title: Stroma-derived miR-214 coordinates tumor dissemination
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-022-02553-5
– volume: 6
  start-page: 18
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb1115
  article-title: MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
  publication-title: J. Ovarian Res.
  doi: 10.1186/1757-2215-6-18
– volume: 250
  start-page: 159
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0165
  article-title: ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors
  publication-title: J. Pathol.
  doi: 10.1002/path.5356
– volume: 29
  start-page: 3545
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb0860
  article-title: TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214
  publication-title: Oncogene
  doi: 10.1038/onc.2010.111
– volume: 6
  start-page: 402
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0830
  article-title: The JAK/STAT signaling pathway: from bench to clinic
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-021-00791-1
– volume: 277
  start-page: 9684
  year: 2002
  ident: 10.1016/j.bbcan.2024.189191_bb0285
  article-title: Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M106157200
– volume: 37
  start-page: 3189
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0195
  article-title: CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2017.5583
– volume: 23
  start-page: 128
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0225
  article-title: Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2020.11767
– volume: 125
  start-page: 55
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0450
  article-title: Dickkopf signaling, beyond Wnt-mediated biology
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2021.11.003
– volume: 43
  start-page: 605
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0625
  article-title: Evaluating the effect of 3′-utr variants in dicer1 and drosha on their tissue-specific expression by mirna target prediction
  publication-title: Curr. Issues Mol. Biol.
  doi: 10.3390/cimb43020044
– volume: 1
  start-page: 639
  year: 2002
  ident: 10.1016/j.bbcan.2024.189191_bb0615
  article-title: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
  publication-title: Mol. Cancer Ther.
– volume: 15
  start-page: 248
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0725
  article-title: miR-424-5p promotes anoikis resistance and lung metastasis by inactivating Hippo signaling in thyroid cancer
  publication-title: Mol Ther Oncolytics
  doi: 10.1016/j.omto.2019.10.008
– volume: 2021
  start-page: 8842554
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0565
  article-title: Evaluation of Hippo pathway and CD133 in radiation resistance in small-cell lung cancer
  publication-title: J. Oncol.
  doi: 10.1155/2021/8842554
– volume: 1
  start-page: 24
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb1150
  article-title: Recent progress in microRNA-based delivery systems for the treatment of human disease
  publication-title: ExRNA
  doi: 10.1186/s41544-019-0024-y
– volume: 110
  start-page: 669
  year: 2002
  ident: 10.1016/j.bbcan.2024.189191_bb0275
  article-title: Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00966-2
– volume: 10
  start-page: 11
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0135
  article-title: Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-017-0306-7
– volume: 35
  start-page: 132
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0965
  article-title: MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-016-0415-y
– volume: 8
  start-page: 5206
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0660
  article-title: MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14123
– volume: 41
  start-page: 736
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1200
  article-title: Development and functional validation of a nano-delivery system of miR-16/polypeptide targeting ovarian cancer cells
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– volume: 486
  start-page: 1129
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0815
  article-title: Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2017.04.008
– volume: 79
  start-page: 2314
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0105
  article-title: Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-3668
– volume: 12
  start-page: 269
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0840
  article-title: HMGA2 as a critical regulator in cancer development
  publication-title: Genes (Basel)
  doi: 10.3390/genes12020269
– volume: 927
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb1100
  article-title: Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7
  publication-title: Gene
  doi: 10.1016/j.gene.2024.148738
– volume: 13
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0680
  article-title: The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling
  publication-title: Front. Pharmacol.
– year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0405
  article-title: Integrated analysis of ovarian cancer stem cells-associated lncRNA-miRNA-mRNA network via microarray and Gene Expression Omnibus database
  publication-title: Res Sq Preprint
– volume: 9
  start-page: 1308
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0760
  article-title: MiRNA-3163 limits ovarian cancer stem-like cells via targeting SOX-2 transcription factor
  publication-title: Noncoding RNA Res
  doi: 10.1016/j.ncrna.2024.06.012
– volume: 39
  start-page: 611
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb1120
  article-title: Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CTBP2
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.08.025
– volume: 112
  start-page: 4220
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0535
  article-title: Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling
  publication-title: Cancer Sci.
  doi: 10.1111/cas.15100
– volume: 22
  start-page: 3525
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0210
  article-title: CD133 Act as an essential marker in ovarian carcinogenesis
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.31557/APJCP.2021.22.11.3525
– volume: 2
  start-page: 900
  year: 2011
  ident: 10.1016/j.bbcan.2024.189191_bb0370
  article-title: Transcriptional regulation of EGR1 by EGF and the ERK signaling pathway in prostate cancer cells, Genes
  publication-title: Cancer
– volume: 14
  start-page: 314
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb1235
  article-title: miRNAs: The road from bench to bedside
  publication-title: Genes (Basel)
  doi: 10.3390/genes14020314
– volume: 13
  start-page: 871
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0090
  article-title: Circulating microRNAs for early diagnosis of ovarian cancer: A systematic review and meta-analysis
  publication-title: Biomolecules
  doi: 10.3390/biom13050871
– volume: 17
  start-page: 211
  year: 2011
  ident: 10.1016/j.bbcan.2024.189191_bb0970
  article-title: David Brown, Dean G Tang, The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
  publication-title: Nat. Med.
  doi: 10.1038/nm.2284
– volume: 22
  start-page: 751
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0380
  article-title: Targeting the transcriptional activity of STAT3 by a novel fusion protein
  publication-title: BMC Cancer
  doi: 10.1186/s12885-022-09837-1
– volume: 48
  start-page: 996
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0330
  article-title: GPR137 inhibits cell proliferation and promotes neuronal differentiation in the neuro2a cells
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-022-03833-4
– volume: 47
  start-page: 2147
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0975
  article-title: MiR-137 suppresses triple-negative breast cancer stemness and tumorigenesis by perturbing BCL11A-DNMT1 interaction
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000491526
– volume: 25
  start-page: 1411
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0835
  article-title: Non-coding RNA Pvt1 promotes cancer stem cell–like traits in nasopharyngeal cancer via inhibiting miR-1207
  publication-title: Pathol. Oncol. Res.
  doi: 10.1007/s12253-018-0453-1
– volume: 8
  start-page: 3538
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0340
  article-title: Clinical impact of microRNAs associated with cancer stem cells as a prognostic factor in ovarian carcinoma
  publication-title: J. Cancer
  doi: 10.7150/jca.20348
– volume: 77
  start-page: 1955
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0820
  article-title: The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-1115
– volume: 17
  start-page: 102
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0925
  article-title: Regulation of miR-30b in cancer development, apoptosis, and drug resistance, Open
  publication-title: Life Sci.
– volume: 14
  start-page: 5093
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0395
  article-title: CEMIP, a promising biomarker that promotes the progression and metastasis of colorectal and other types of cancer
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14205093
– volume: 10
  start-page: 13958
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0805
  article-title: STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-70948-5
– volume: 14
  start-page: 3404
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0110
  article-title: miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression
  publication-title: J. Cancer
  doi: 10.7150/jca.87692
– volume: 8
  start-page: 3080
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0215
  article-title: Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis, Int
  publication-title: J Clin Exp Med
– volume: 17
  start-page: 3425
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0780
  article-title: MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2
  publication-title: Oncol. Lett.
– volume: 12
  start-page: 1
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0775
  article-title: CD44S induces miR-629-3p expression in association with cisplatin resistance in head and neck cancer cells
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12040856
– volume: 27
  start-page: 1134
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0025
  article-title: Impact of recurrence of ovarian cancer on quality of life and outlook for the future
  publication-title: Int. J. Gynecol. Cancer
  doi: 10.1097/IGC.0000000000001023
– volume: 116
  start-page: 66
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb1225
  article-title: MicroRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2016.379
– volume: 24
  start-page: 10337
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0480
  article-title: The recent research progress of NF-κB signaling on the proliferation, migration, invasion, immune escape and drug resistance of glioblastoma
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms241210337
– volume: 299
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0490
  article-title: The inhibitor of κB kinase β (IKKβ) phosphorylates IκBα twice in a single binding event through a sequential mechanism
  publication-title: J. Biol. Chem.
  doi: 10.1016/j.jbc.2022.102796
– volume: 4
  start-page: 10
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1155
  article-title: Recent advances in miRNA delivery systems
  publication-title: Methods Protoc
  doi: 10.3390/mps4010010
– volume: 2
  start-page: 89
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb1035
  article-title: Evaluation of miRNA-derived extracellular vesicles as biomarkers in ovarian cancer stem cells
  publication-title: Cancer Screening and Prevention
– volume: 10
  start-page: 2951
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0205
  article-title: Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: Evidence from meta-analysis
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S136549
– volume: 9
  start-page: 1091
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0570
  article-title: The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
  publication-title: Mol. Oncol.
  doi: 10.1016/j.molonc.2015.01.007
– volume: 23
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1055
  article-title: Tumor suppressor miRNA-503 inhibits cell invasion in head and neck cancer through the Wnt signaling pathway via the WNT3A/MMP molecular axis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms232415900
– volume: 11
  start-page: 69
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0140
  article-title: Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-018-0439-3
– volume: 19
  start-page: 2909
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0790
  article-title: Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells
  publication-title: Oncol. Lett.
– volume: 382
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0665
  article-title: Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2019.06.007
– volume: 12
  start-page: 328
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb1140
  article-title: MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
  publication-title: Cancer Biol. Med.
– volume: 15
  start-page: 987
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb1270
  article-title: Challenges identifying efficacious miRNA therapeutics for cancer
  publication-title: Expert Opin. Drug Discov.
  doi: 10.1080/17460441.2020.1765770
– volume: 14
  start-page: 2796
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0850
  article-title: Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis
  publication-title: Mol. Oncol.
  doi: 10.1002/1878-0261.12762
– volume: 4
  start-page: S1064
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb0695
  article-title: MET receptor tyrosine kinase
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/01.JTO.0000361752.86918.09
– volume: 95
  start-page: 29
  year: 1998
  ident: 10.1016/j.bbcan.2024.189191_bb0320
  article-title: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81780-8
– volume: 14
  start-page: 28
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0030
  article-title: Targeting ovarian cancer stem cells: a new way out
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-023-03244-4
– volume: 7
  start-page: 68229
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0230
  article-title: Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11920
– volume: 102
  start-page: 147
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0795
  article-title: miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2018.03.018
– volume: 40
  start-page: 5131
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0315
  article-title: ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers
  publication-title: Oncogene
  doi: 10.1038/s41388-021-01913-3
– volume: 1
  start-page: 63
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb1245
  article-title: miRNA-based therapeutic strategies
  publication-title: Curr. Anesthesiol. Rep.
– volume: 23
  start-page: 10064
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1060
  article-title: The distinct roles of LKB1 and AMPK in p53-dependent apoptosis induced by cisplatin
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms231710064
– volume: 1
  start-page: 210
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb0435
  article-title: Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.127
– volume: 8
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0365
  article-title: Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells
  publication-title: PLoS One
  doi: 10.1371/annotation/ee15c511-4f60-4415-a0f4-c99dcf1bb2e2
– volume: 57
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0690
  article-title: MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.13582
– volume: 8
  start-page: 12522
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb1005
  article-title: Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-30978-6
– volume: 17
  start-page: 102
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb1300
  article-title: Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-024-01429-w
– volume: 6
  start-page: 34730
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0130
  article-title: Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer
  publication-title: Sci. Rep.
  doi: 10.1038/srep34730
– volume: 36
  start-page: 1881
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0645
  article-title: MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2790-3
– volume: 19
  start-page: 618
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0265
  article-title: Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
  publication-title: BMC Cancer
  doi: 10.1186/s12885-019-5824-9
– volume: 10
  start-page: 630
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb1205
  article-title: MicroRNA-155-5p diminishes in vitro ovarian cancer cell viability by targeting HIF1α expression
  publication-title: Adv Pharm Bull
  doi: 10.34172/apb.2020.076
– volume: 5
  start-page: 5370
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0545
  article-title: The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms6370
– volume: 108
  start-page: 719
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0245
  article-title: SOX2 is required to maintain cancer stem cells in ovarian cancer
  publication-title: Cancer Sci.
  doi: 10.1111/cas.13186
– volume: 18
  start-page: 2256
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0890
  article-title: miR-600 acts as a bimodal switch that regulates breast cancer stem cell fate through WNT signaling
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.02.016
– volume: 14
  start-page: 4573
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0415
  article-title: Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-40213-0
– volume: 44
  start-page: 2437
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0740
  article-title: Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells
  publication-title: Head Neck
  doi: 10.1002/hed.27155
– volume: 111
  start-page: 17266
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0120
  article-title: Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1419599111
– volume: 40
  start-page: 1574
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0610
  article-title: S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53
  publication-title: Oncol. Rep.
– volume: 14
  start-page: 1320887
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0845
  article-title: HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2024.1320887
– volume: 7
  start-page: 63342
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0505
  article-title: Rab27A mediated by NF-κB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11454
– volume: 74
  start-page: 463
  year: 1993
  ident: 10.1016/j.bbcan.2024.189191_bb0600
  article-title: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
  publication-title: Cell
  doi: 10.1016/0092-8674(93)80048-J
– volume: 11
  start-page: 36
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0220
  article-title: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: Studies based on the CRISPR/Cas9 system
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-018-0403-2
– volume: 18
  start-page: 64
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0175
  article-title: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-020-02243-w
– volume: 11
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb1145
  article-title: Identification of specific miRNA signature in paired sera and tissue samples of Indian women with triple negative breast cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0158946
– volume: 14
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb1220
  article-title: Human CAP cells represent a novel source for functional, miRNA-loaded exosome production
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0221679
– volume: 6
  start-page: 13
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0350
  article-title: Activation of the EGF receptor by ligand binding and oncogenic mutations: The rotation model
  publication-title: Cells
  doi: 10.3390/cells6020013
– volume: 10
  start-page: 272
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb0810
  article-title: miR-1246 targets CCNG2 to enhance cancer stemness and chemoresistance in oral carcinomas
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers10080272
– volume: 32
  start-page: 2555
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0990
  article-title: Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
  publication-title: Oncogene
  doi: 10.1038/onc.2012.275
– volume: 9
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0755
  article-title: miR-181a-2-3p stimulates gastric cancer progression via targeting MYLK
  publication-title: Front. Bioeng. Biotechnol.
– volume: 38
  start-page: 3064
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb1070
  article-title: Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2017.5938
– volume: 24
  start-page: 279
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0655
  article-title: MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN
  publication-title: Cancer Biomark.
  doi: 10.3233/CBM-182182
– volume: 501
  start-page: 486
  year: 2018
  ident: 10.1016/j.bbcan.2024.189191_bb1030
  article-title: MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.05.018
– volume: 12
  start-page: 561
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0375
  article-title: Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-03844-z
– volume: 12
  start-page: 101
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0465
  article-title: NF-κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-α and TGF-β, Int
  publication-title: J Clin Exp Pathol
– volume: 15
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0235
  article-title: Immunohistochemical evaluation of Notch1 in ovarian tumours and its prognostic implications
  publication-title: Cureus
– volume: 23
  start-page: 7167
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1240
  article-title: MicroRNA-based diagnosis and therapy
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23137167
– volume: 36
  start-page: 4001
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0930
  article-title: Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
  publication-title: Oncogene
  doi: 10.1038/onc.2017.33
– volume: 11
  start-page: 383
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0040
  article-title: Presence and role of stem cells in ovarian cancer, World
  publication-title: J. Stem Cells
– volume: 7
  start-page: 95
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0510
  article-title: Notch signaling pathway: architecture, disease, and therapeutics
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-022-00934-y
– volume: 15
  start-page: 3781
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0785
  article-title: Linc00662 sponges miR-15b-5p to promote hypopharyngeal squamous cell carcinoma progression by facilitating cancer stem cell-like phenotypes
  publication-title: J. Cancer
  doi: 10.7150/jca.95852
– volume: 30
  start-page: 43
  year: 2005
  ident: 10.1016/j.bbcan.2024.189191_bb0495
  article-title: Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2004.11.009
– volume: 81
  start-page: 10
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0700
  article-title: miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34+ cells partially via SERPINE1
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-023-05036-8
– volume: 5
  start-page: 1197
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0020
  article-title: Management of relapsed ovarian cancer: a review
  publication-title: Springerplus
  doi: 10.1186/s40064-016-2660-0
– volume: 15
  start-page: 52
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0885
  article-title: miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-022-00981-7
– volume: 5
  start-page: 304
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb0015
  article-title: Mechanisms of chemotherapy resistance in ovarian cancer
  publication-title: Cancer Drug Resistance
– volume: 13
  start-page: 16
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb1025
  article-title: Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-020-00618-7
– volume: 14
  start-page: 228
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0310
  article-title: LncRNA HOTAIR down-expression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing TGF-β1 and ZEB1
  publication-title: Discov. Oncol.
  doi: 10.1007/s12672-023-00846-5
– volume: 27
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0720
  article-title: Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway
  publication-title: Transl. Oncol.
  doi: 10.1016/j.tranon.2022.101578
– volume: 14
  start-page: 606
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0915
  article-title: HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-06076-5
– volume: 3
  start-page: 1302
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb1190
  article-title: Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-13-0159
– volume: 24
  start-page: 72
  year: 2010
  ident: 10.1016/j.bbcan.2024.189191_bb0560
  article-title: A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP
  publication-title: Genes Dev.
  doi: 10.1101/gad.1843810
– volume: 11
  start-page: 23
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0250
  article-title: SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study
  publication-title: Cell Biosci.
  doi: 10.1186/s13578-021-00539-y
– volume: 14
  start-page: 154
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0710
  article-title: RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-021-00917-7
– volume: 14
  start-page: 177
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0900
  article-title: PVT1/miR-136/Sox2/UPF1 axis regulates the malignant phenotypes of endometrial cancer stem cells
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-05651-0
– volume: 6
  start-page: 9313
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0185
  article-title: Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3220
– volume: 14
  start-page: 648
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb0705
  article-title: Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
  publication-title: Cell Cycle
  doi: 10.4161/15384101.2014.994966
– volume: 47
  start-page: 202
  year: 2011
  ident: 10.1016/j.bbcan.2024.189191_bb1010
  article-title: MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2010.12.001
– volume: 13
  start-page: 4178
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb1110
  article-title: Ovarian cancer and cancer stem cells—cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and oncology
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13164178
– volume: 14
  start-page: 65
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb1210
  article-title: Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
  publication-title: Discov. Oncol.
  doi: 10.1007/s12672-023-00674-7
– volume: 282
  start-page: 19426
  year: 2007
  ident: 10.1016/j.bbcan.2024.189191_bb0360
  article-title: Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M610054200
– volume: 20
  start-page: 897
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0620
  article-title: MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2
  publication-title: Cancer Biol. Ther.
  doi: 10.1080/15384047.2019.1579960
– volume: 65
  start-page: 3025
  year: 2005
  ident: 10.1016/j.bbcan.2024.189191_bb0125
  article-title: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-3931
– volume: 17
  start-page: 8
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb0190
  article-title: The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: A meta-analysis
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-016-0376-4
– volume: 19
  start-page: 3
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb0580
  article-title: GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy
  publication-title: Biol. Direct
  doi: 10.1186/s13062-023-00449-8
– volume: 77
  start-page: 1613
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0530
  article-title: MicroRNA-874-3p/ADAM (A disintegrin and metalloprotease) 19 mediates macrophage activation and renal fibrosis after acute kidney injury
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.120.16900
– volume: 25
  start-page: 217
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb1090
  article-title: Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer
  publication-title: Innate Immun.
  doi: 10.1177/1753425919840702
– volume: 28
  start-page: 53
  year: 2023
  ident: 10.1016/j.bbcan.2024.189191_bb0940
  article-title: EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells
  publication-title: Cell. Mol. Biol. Lett.
  doi: 10.1186/s11658-023-00471-8
– volume: 21
  start-page: 93
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0440
  article-title: Balu Senthil Kumar, Kumar Alan Prem, Millward Michael, Arunasalam Dharmarajan, Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
  publication-title: Oncol. Res.
– volume: 14
  start-page: 283
  year: 2015
  ident: 10.1016/j.bbcan.2024.189191_bb1165
  article-title: RNA-based viral vectors RNA-based viral vectors
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/14760584.2015.979798
– volume: 12
  start-page: 15437
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1000
  article-title: ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-19290-6
– volume: 45
  start-page: 63
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0335
  article-title: TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2021.8014
– volume: 38
  start-page: 200
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0675
  article-title: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-019-1179-y
– volume: 15
  start-page: R54
  year: 2013
  ident: 10.1016/j.bbcan.2024.189191_bb0520
  article-title: Notch activation stimulates migration of breast cancer cells and promotes tumor growth
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr3447
– volume: 41
  start-page: 99
  year: 2021
  ident: 10.1016/j.bbcan.2024.189191_bb0870
  article-title: HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma
  publication-title: Oncogene
  doi: 10.1038/s41388-021-02014-x
– volume: 35
  start-page: 2027
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb0305
  article-title: Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3/-catenin/ZEB1 signaling pathway
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.4591
– volume: 49
  start-page: 361
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0935
  article-title: Epithelial-mesenchymal plasticity in cancer progression and metastasis
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2019.04.010
– volume: 180
  start-page: 1159
  year: 2012
  ident: 10.1016/j.bbcan.2024.189191_bb0170
  article-title: ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2011.11.015
– volume: 10
  start-page: 81
  year: 2024
  ident: 10.1016/j.bbcan.2024.189191_bb1080
  article-title: CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation
  publication-title: Cell Death Dis.
  doi: 10.1038/s41420-024-01858-y
– volume: 117
  start-page: 1665
  year: 2017
  ident: 10.1016/j.bbcan.2024.189191_bb1050
  article-title: Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2017.335
– volume: 14
  start-page: 85
  year: 2014
  ident: 10.1016/j.bbcan.2024.189191_bb0960
  article-title: MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-85
– volume: 9
  start-page: 139
  year: 2022
  ident: 10.1016/j.bbcan.2024.189191_bb1230
  article-title: Beyond safety: mapping the ethical debate on heritable genome editing interventions
  publication-title: Humanit Soc Sci Commun
  doi: 10.1057/s41599-022-01147-y
– volume: 11
  start-page: 287
  year: 2019
  ident: 10.1016/j.bbcan.2024.189191_bb0010
  article-title: Ovarian cancer in the world: Epidemiology and risk factors
  publication-title: Int. J. Women's Health
  doi: 10.2147/IJWH.S197604
– volume: 306
  start-page: 461
  year: 2020
  ident: 10.1016/j.bbcan.2024.189191_bb0080
  article-title: Identification of microRNA expression profiles of CD44+ ovarian cancer stem cells
  publication-title: Arch. Gynecol. Obstet.
– volume: 7
  start-page: 62019
  year: 2016
  ident: 10.1016/j.bbcan.2024.189191_bb1135
  article-title: Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11495
SSID ssj0015336
Score 2.4674456
SecondaryResourceType review_article
Snippet Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate. Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 189191
SubjectTerms Animals
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
CSC
Female
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs - genetics
miRNAs
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Ovarian cancer
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Prognostic biomarkers
Signal Transduction
Therapeutic agents
Title Roles of miRNAs in regulating ovarian cancer stemness
URI https://dx.doi.org/10.1016/j.bbcan.2024.189191
https://www.ncbi.nlm.nih.gov/pubmed/39353485
https://www.proquest.com/docview/3112513094
Volume 1879
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFH4UxeUiWre6lBE8GutMJmnmWIpSFXtwgd6GTGYCFU1LrYIXf7vvZZKCBz14TMiQ4ZuXt-QtH8Ap6nyRcpMHxE4YSBnhJ4VmI8hyYwXP8zi09L_jbhgPnuTNKBo1oF_3wlBZZaX7vU4vtXV1p1Oh2ZmOx50HSupJrkZUBcmFoI5yKbsk5edfizIPcmd8vvJCUsZzVE8eKmu8jMH9Y5Ao5DlPFFf8N-v0m_dZWqGrTdio3EfW8zvcgoYrmrDiCSU_m7DWr_nbmrB6V6XNtyG6p7FNbJKz1_H9sPfGxgWbeRJ6tFxs8oEBc1qwjCRgxmi0MynAHXi6unzsD4KKLyHIwkjNg5zoW5xwxqrU4sforHRo31WSKSUjYwz6Gtx1ucrRXvHUmNjSNPvI8YxGyrhwF5aKSeH2gcXU4Wowek1sJLmVJrFJ1k0FohmKTIkWiBonnVXDxInT4kXXVWPPugRXE7jag9uCs8WiqZ-l8ffjcX0A-odIaNT2fy88qY9LI-aUAUkLN3l_0yEnfy7EkLYFe_4cFzuhHuVQJtHBf197COt05RsVj2BpPnt3x-ixzE27FMk2LPeubwfDb3ku5aI
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9tAEB5RUAsX1KY8Umi7legNE3a9drwHDoiHQiE58JByW7zetRQEDkoCiEv_FH-QGa8diQMckLjaXtv6Zj0Pz-MD2ECdL1Ju8oDYCQMpI_yk0GwEWW6s4Hkeh5b-d3R7cedC_utH_Rl4qnthqKyy0v1ep5faujrSqtBs3Q4GrTNK6kmu-lQFyYVoV5WVx-7xAeO28c7RPgr5rxCHB-d7naCiFgiyMFKTICemEyecsSq1uG-dlQ5NoUoypWRkjEGzzF2bqxxVO0-NiS0Nfo8cz2j6igvxvp9gTqK6INqErf_TuhLyn3yCdFtSirVfjzoqi8qMQcAwKhVyiyeKK_6aOXzN3S3N3uFXWKz8VbbrIfkGM65owGfPYPnYgPm9mjCuAV-6VZ7-O0SnNCeKDXN2Mzjt7Y7ZoGAjz3qPppIN7zFCTwuW0ZYbMZolTRp3CS4-BMVlmC2GhVsFFlNLrcFwObGR5FaaxCZZOxWIZigyJZogapx0Vk0vJxKNa12XqV3pElxN4GoPbhM2p4tu_fCOty-PawHoF3tQo3l5e-GfWlwaMaeUS1q44d1Yh5wcyBBj6CaseDlO34SaokOZRD_e-9jfMN85757ok6Pe8Ros0BnfJbkOs5PRnfuJ7tLE_Cq3J4PLj_4engHh3iDX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Roles+of+miRNAs+in+regulating+ovarian+cancer+stemness&rft.jtitle=Biochimica+et+biophysica+acta.+Reviews+on+cancer&rft.au=Chong%2C+Zhi-Xiong&rft.date=2024-11-01&rft.issn=0304-419X&rft.volume=1879&rft.issue=6&rft.spage=189191&rft_id=info:doi/10.1016%2Fj.bbcan.2024.189191&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbcan_2024_189191
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-419X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-419X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-419X&client=summon